<SEC-DOCUMENT>0001213900-23-097013.txt : 20231219
<SEC-HEADER>0001213900-23-097013.hdr.sgml : 20231219
<ACCEPTANCE-DATETIME>20231219172107
ACCESSION NUMBER:		0001213900-23-097013
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20231219
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231219
DATE AS OF CHANGE:		20231219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pasithea Therapeutics Corp.
		CENTRAL INDEX KEY:			0001841330
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				851591963
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40804
		FILM NUMBER:		231498517

	BUSINESS ADDRESS:	
		STREET 1:		2110 NARCISSUS CT
		CITY:			VENICE
		STATE:			CA
		ZIP:			90291
		BUSINESS PHONE:		8184226172

	MAIL ADDRESS:	
		STREET 1:		2110 NARCISSUS CT
		CITY:			VENICE
		STATE:			CA
		ZIP:			90291
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea190360-8k_pasithea.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:KTTA="http://pasithea.com/20231219">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_KTTA_pasithea.com_20231219 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20231219_20231219 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0001841330 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2023-12-19" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2023-12-19" name="dei:EntityCentralIndexKey">0001841330</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ktta-20231219.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2023-12-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001841330</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-19</xbrli:startDate>
        <xbrli:endDate>2023-12-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-192023-12-19_custom_CommonStockParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001841330</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">KTTA:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-19</xbrli:startDate>
        <xbrli:endDate>2023-12-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-192023-12-19_custom_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001841330</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">KTTA:WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-19</xbrli:startDate>
        <xbrli:endDate>2023-12-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90A_edei--DocumentType_c20231219__20231219_zR9N3QCPc2Id"><ix:nonNumeric contextRef="AsOf2023-12-19" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 Or 15(D) of</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>The Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<span id="xdx_908_edei--DocumentPeriodEndDate_c20231219__20231219_zZ1gYew78PDa"><ix:nonNumeric contextRef="AsOf2023-12-19" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">December 19, 2023</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90F_edei--EntityRegistrantName_c20231219__20231219_z10nqULGCB44"><ix:nonNumeric contextRef="AsOf2023-12-19" name="dei:EntityRegistrantName">Pasithea Therapeutics Corp.</ix:nonNumeric></span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its
charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20231219__20231219_zWC2WbNYLr6k"><ix:nonNumeric contextRef="AsOf2023-12-19" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b><span id="xdx_90F_edei--EntityFileNumber_c20231219__20231219_zjkktj0cT2F4"><ix:nonNumeric contextRef="AsOf2023-12-19" name="dei:EntityFileNumber">001-40804</ix:nonNumeric></span></b></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><b><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20231219__20231219_zaOf2jBzCtFb"><ix:nonNumeric contextRef="AsOf2023-12-19" name="dei:EntityTaxIdentificationNumber">85-1591963</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">(State or other jurisdiction <br />
of incorporation)</td>
    <td>&#160;</td>
    <td style="text-align: center">(Commission File Number)</td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(IRS Employer<br />
Identification No.)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 49%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90A_edei--EntityAddressAddressLine1_c20231219__20231219_zUN53pzHrkHd"><ix:nonNumeric contextRef="AsOf2023-12-19" name="dei:EntityAddressAddressLine1">4400 Route 9 South</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressAddressLine2_c20231219__20231219_zrEdEmxkCqy1"><ix:nonNumeric contextRef="AsOf2023-12-19" name="dei:EntityAddressAddressLine2">Suite 3100</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90B_edei--EntityAddressCityOrTown_c20231219__20231219_zduRPr7tOVoe"><ix:nonNumeric contextRef="AsOf2023-12-19" name="dei:EntityAddressCityOrTown">Miami Beach</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressStateOrProvince_c20231219__20231219_zegbpONvwvzj"><ix:nonNumeric contextRef="AsOf2023-12-19" name="dei:EntityAddressStateOrProvince">FL</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 49%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_905_edei--EntityAddressPostalZipCode_c20231219__20231219_zSsveidowqZj"><ix:nonNumeric contextRef="AsOf2023-12-19" name="dei:EntityAddressPostalZipCode">33139</ix:nonNumeric></span></b></p></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">(Address of principal executive offices)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">(Zip Code)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including area code:
<b>(<span id="xdx_908_edei--CityAreaCode_c20231219__20231219_zY15PgdKfCs4"><ix:nonNumeric contextRef="AsOf2023-12-19" name="dei:CityAreaCode">786</ix:nonNumeric></span>) <span id="xdx_90B_edei--LocalPhoneNumber_c20231219__20231219_zOf06cTVMytk"><ix:nonNumeric contextRef="AsOf2023-12-19" name="dei:LocalPhoneNumber">977-3380</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;(Former name or former address, if changed
since last report.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.
below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_edei--WrittenCommunications_c20231219__20231219_zl6Z761sHVz6"><ix:nonNumeric contextRef="AsOf2023-12-19" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify">Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)</td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_edei--SolicitingMaterial_c20231219__20231219_zPWPkMpf9Fz1"><ix:nonNumeric contextRef="AsOf2023-12-19" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)</td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_edei--PreCommencementTenderOffer_c20231219__20231219_zYPZrThKO2Ke"><ix:nonNumeric contextRef="AsOf2023-12-19" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))</td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_edei--PreCommencementIssuerTenderOffer_c20231219__20231219_zkT11idoJzKd"><ix:nonNumeric contextRef="AsOf2023-12-19" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))</td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; text-align: center; width: 32%">Title of each class</td>
    <td style="vertical-align: top; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; text-align: center; width: 32%">Trading Symbol(s)</td>
    <td style="vertical-align: top; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; text-align: center; width: 32%">Name of each exchange on which registered</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span id="xdx_90C_edei--Security12bTitle_c20231219__20231219__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zhlZzfY8r1Je"><ix:nonNumeric contextRef="From2023-12-192023-12-19_custom_CommonStockParValue0.0001PerShareMember" name="dei:Security12bTitle">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_900_edei--TradingSymbol_c20231219__20231219__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zQwpnjARGQFg"><ix:nonNumeric contextRef="From2023-12-192023-12-19_custom_CommonStockParValue0.0001PerShareMember" name="dei:TradingSymbol">KTTA</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center">The <span id="xdx_908_edei--SecurityExchangeName_c20231219__20231219__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zAlaqOcS3lq7"><ix:nonNumeric contextRef="From2023-12-192023-12-19_custom_CommonStockParValue0.0001PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span id="xdx_907_edei--Security12bTitle_c20231219__20231219__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember_zYy0HinVSSzf"><ix:nonNumeric contextRef="From2023-12-192023-12-19_custom_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" name="dei:Security12bTitle">Warrants to purchase shares of Common Stock, par value $0.0001 per share</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90E_edei--TradingSymbol_c20231219__20231219__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember_zRKhfjKaHMb8"><ix:nonNumeric contextRef="From2023-12-192023-12-19_custom_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" name="dei:TradingSymbol">KTTAW</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center">The <span id="xdx_900_edei--SecurityExchangeName_c20231219__20231219__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember_zcpvGVL8hUoj"><ix:nonNumeric contextRef="From2023-12-192023-12-19_custom_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right">Emerging growth company
<span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_edei--EntityEmergingGrowthCompany_c20231219__20231219_z5IWwhRgVdch"><ix:nonNumeric contextRef="AsOf2023-12-19" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-align: center; text-indent: 2in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_edei--EntityExTransitionPeriod_c20231219__20231219_zCPUdvEYmiyc"><ix:nonNumeric contextRef="AsOf2023-12-19" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As reported in Item 5.07 below,
on December 19, 2023, at the Annual Meeting (as defined below), the stockholders of Pasithea Therapeutics Corp. (the &#8220;Company&#8221;)
approved the Pasithea Therapeutics Corp. 2023 Stock Incentive Plan (the &#8220;2023 Incentive Plan&#8221;). The board of directors of
the Company (the &#8220;Board&#8221;) had previously approved the 2023 Incentive Plan, subject to stockholder approval, and the 2023 Incentive
Plan became effective upon such stockholder approval.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A copy of the 2023 Incentive Plan
is attached as Exhibit 10.1 hereto, and is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 5.07 Submission of Matters to a Vote of Security Holders. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><i>2023 Annual Meeting</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">On December 19, 2023, the
Company convened its 2023 annual meeting of stockholders (the &#8220;Annual Meeting&#8221;), which had been previously adjourned on November
29, 2023. At the Annual Meeting, the Company&#8217;s stockholders voted on the four proposals listed below. The proposals are described
in detail in the Company&#8217;s definitive proxy statement on Schedule 14A for the Annual Meeting filed with the Securities and Exchange
Commission on October 26, 2023 (the &#8220;Proxy Statement&#8221;). Of the 20,836,623 shares of common stock of the Company, par value
$0.0001 per share (the &#8220;Common Stock&#8221;), outstanding and entitled to vote at the Annual Meeting, 14,770,804 shares of Common
Stock were represented in person or by proxy at the Annual Meeting, thereby constituting a quorum.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">The voting results on each
of the proposals acted upon at the Annual Meeting are set forth below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Proposal 1</b> related to the election of each
of Dr.&#160;Tiago Reis Marques, Prof. Lawrence Steinman, Simon Dumesnil, Dr.&#160;Emer Leahy and Alfred Novak, each to serve a one-year
term expiring at the 2024 annual meeting of stockholders, or if Proposal 5(A) (relating to the classification of the Board) is adopted,
to hold office until the annual meeting of stockholders in accordance with the class of director to which each nominee will be assigned.
The appointment of each of the foregoing directors was approved by a plurality of the votes cast at the Annual Meeting as follows:</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">FOR</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">WITHHELD</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">BROKER<br /> NON-VOTES</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Dr. Tiago Reis Marques</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">11,433,844</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">270,547</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,066,413</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prof. Lawrence Steinman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,434,292</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">270,099</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,066,413</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Simon Dumesnil</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,409,027</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">295,364</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,066,413</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Dr. Emer Leahy</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,408,775</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">295,616</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,066,413</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Alfred Novak</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,369,003</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">335,388</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,066,413</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Proposal 2</b> related to the adoption and
approval of an amendment to the Company&#8217;s Amended and Restated Certificate of Incorporation, as amended and/or restated from time
to time (the &#8220;Certificate&#8221;), at the discretion of the Board to effect a reverse stock split of the Company&#8217;s issued
shares of Common Stock, at a specific ratio, ranging from one-for-two&#160;(1:2) to one-for-twenty&#160;(1:20), at any time prior to the
one-year&#160;anniversary date of the Annual Meeting, with the exact ratio to be determined by the Board without further approval or authorization
of the Company&#8217;s stockholders, with a corresponding reduction in the number of authorized shares of Common Stock (although not below
100,000,000&#160;shares). Proposal 2 was approved by a majority of votes cast at the Annual Meeting, based upon the following votes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 24%"><b>FOR</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 24%"><b>AGAINST</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 25%"><b>ABSTAIN</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 24%"><b>BROKER NON-VOTES</b></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: center">13,432,469</td>
    <td>&#160;</td>
    <td style="text-align: center">1,181,664</td>
    <td>&#160;</td>
    <td style="text-align: center">156,671</td>
    <td>&#160;</td>
    <td style="text-align: center">N/A</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29.05pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29.05pt"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29.05pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Proposal 3</b> related to the approval of the
2023 Incentive Plan, the reservation of 2,500,000 shares of Common Stock for issuance thereunder, and the approval of the rollover of
all unused shares of Common Stock reserved under the 2021 Incentive Plan and the shares from outstanding awards that are canceled or forfeited
under the 2021 Incentive Plan for issuance under the 2023 Incentive Plan. Proposal 3 was approved by a majority of votes cast at the Annual
Meeting, based upon the following votes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 24%"><b>FOR</b></td>
    <td style="text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 24%"><b>AGAINST</b></td>
    <td style="text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 25%"><b>ABSTAIN</b></td>
    <td style="text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 24%"><b>BROKER NON-VOTES</b></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: center">9,196,502</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">1,520,422</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">987,467</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">3,066,413</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Proposal 6 </b>related to the ratification
of the appointment of Marcum LLP as our independent registered public accounting firm for the fiscal year ending December&#160;31, 2023.
Proposal 6 was approved by a majority of votes cast at the Annual Meeting, based upon the following votes:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 24%"><b>FOR</b></td>
    <td style="text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 24%"><b>AGAINST</b></td>
    <td style="text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 25%"><b>ABSTAIN</b></td>
    <td style="text-align: center; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 24%"><b>BROKER NON-VOTES</b></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: center">13,742,119</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">992,581</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">36,104</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">N/A</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in"><i>Adjourned Meeting</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.45in">On December 19, 2023, the Company
also partially adjourned the Annual Meeting in order to provide stockholders additional time to vote on certain additional proposals to
amend the Certificate, specifically Proposal 4 (relating to the adoption and approval of an amendment and restatement of the Certificate),
Proposal 5(A) (relating to the classification of the Board and removal of directors only for cause), Proposal 5(B) (relating to the prohibition
on the ability of stockholders to take action by written consent), and Proposal 5(C) (the requirement for holders of at least two-thirds
of all then-outstanding shares of Common Stock to amend the Company&#8217;s bylaws) (collectively, the &#8220;Adjourned Proposals&#8221;).
The Adjourned Proposals require a heightened voting standard for approval, namely the affirmative vote of holders of a majority of the
voting power of the issued and outstanding shares of Common Stock that are entitled to vote thereon, with broker non-votes having the
same effect as a vote &#8220;against.&#8221; The Board believes approval of the Adjourned Proposals is advisable and in the best interests
of the Company and its stockholders for the reasons described in the Proxy Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">The adjourned Annual Meeting
will resume solely with respect to Proposals 4, 5(A), 5(B) and 5(C) at 9:00 a.m. Eastern Time on December 28, 2023. The adjourned Annual
Meeting will be reconvened solely with respect to the Adjourned Proposals on December 28, 2023 at 9:00 a.m. Eastern Time at www.virtualshareholdermeeting.com/KTTA2023
(the &#8220;Adjourned Meeting&#8221;). The original record date of October 12, 2023 remains the same for the Adjourned Meeting. Stockholders
of record may attend the virtual webcast meeting by logging in through the same method as set forth in the Proxy Statement. The Board
believes approval of the Adjourned Proposals are advisable and in the best interests of the Company and its stockholders for the reasons
described in the Proxy Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.45in"><b>Voting for the Approved Proposals
has now closed, and those proposals were approved by stockholders at the Annual Meeting. Voting remains open only as to the Adjourned
Proposals, and these are the only proposals that will be voted upon at the Adjourned Meeting</b>. Stockholders who have already voted
their shares on the Adjourned Proposals do not need to vote again. Proxies previously submitted will be voted at the Adjourned Meeting,
and stockholders who have previously submitted a proxy or otherwise voted on the Adjourned Proposals need not take any action.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.45in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.45in">The Company encourages all stockholders,
as of the record date on October 12, 2023, who have not yet voted on the Adjourned Proposals to do so promptly. Stockholders may use the
Proxy Card that they were originally provided with or vote in the manner as set forth in the Proxy Statement. Stockholders needing assistance
with casting or modifying their&#160;vote, should contact&#160;the Company&#8217;s&#160;proxy&#160;solicitor, Alliance Advisors,&#160;toll
free at (888) 490-5085.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><b>(d)</b></td><td style="text-align: justify"><b>Exhibits.</b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; width: 9%"><b>Exhibit No.</b></td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="padding-bottom: 1.5pt; width: 90%"><b>&#160;</b></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>10.1</td>
    <td>&#160;</td>
    <td><a href="ea190360ex10-1_pasithea.htm">Pasithea Therapeutics Corp. 2023 Stock Incentive Plan.</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>104</td>
    <td>&#160;</td>
    <td>Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3"><b>PASITHEA THERAPEUTICS CORP.</b></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>Dated: December 19, 2023</td>
    <td>By:</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">/s/ <i>Tiago Reis Marques</i></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 4%">&#160;</td>
    <td style="width: 5%">Name: </td>
    <td style="width: 31%">Tiago Reis Marques</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>Title:</td>
    <td>Chief Executive Officer</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJydkEFOwzAQRU/QO4willXrGGVBdhCVCpFC1FYtW5NOqNXEE42d0h6JW+I4rdiwAcuSNZr/3/xxFI2jOT3qGhneHpY5rLFpa+UQllghoynRK7Kn5xT8u8QPbR0r40J5NWbkPeg9yUSK0jeC9Kgt7lKI5TS+m8pbEDJNEigW0ajvZ2QqvUPjtKpBmR0UTC1rdIrPA2GtTmSoOYdRG2SryXjcRAztL5AilvBCR/VJfLCQ51k0GocziuZMXetVs5ND0zthVmPjx9nB/XNDmrKzjpp0q7hfzq6p6LjcK4urvWK0r5VfsSGzclQeCsUbVXcoJkKIuEAOmgU278geFQspY3F/SXklgiNoL0ywAQpUwYCFwB1DqxiOPRpuBji0/neD+pew/43055nftNqmKA== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ea190360ex10-1_pasithea.htm
<DESCRIPTION>PASITHEA THERAPEUTICS CORP. 2023 STOCK INCENTIVE PLAN
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Pasithea
Therapeutics CORP.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>2023
STOCK Incentive Plan </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Establishment and Purpose</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1 The purpose of Pasithea
Therapeutics Corp.&rsquo;s 2023 Stock Incentive Plan (the &ldquo;<B>Plan</B>&rdquo;) is to provide a means whereby eligible employees,
officers, non-employee directors and other individual service providers develop a sense of proprietorship and personal involvement in
the development and financial success of the Company (as defined herein) and to encourage them to devote their best efforts to the business
of the Company, thereby advancing the interests of the Company and its stockholders. The Company, by means of the Plan, seeks to retain
the services of such eligible persons and to provide incentives for such persons to exert maximum efforts for the success of the Company
and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.2 The Plan permits the grant
of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance
Shares, Performance Units, Incentive Bonus Awards, Other Cash-Based Awards and Other Stock-Based Awards. This Plan shall become effective
upon the date set forth in Section 17.1 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Definitions</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Wherever the following capitalized
terms are used in the Plan, they shall have the meanings specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1 &ldquo;<B>Affiliate</B>&rdquo;
means, with respect to a Person, a Person that directly or indirectly Controls, or is Controlled by, or is under common Control with,
such Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2 &ldquo;<B>Applicable Law</B>&rdquo;
means the requirements relating to the administration of equity-based awards or equity compensation plans under U.S. state corporate laws,
U.S. federal and state securities laws, the Code, any stock exchange or quotation system on which the Common Stock is listed or quoted
and the applicable laws of any foreign country or jurisdiction that applies to Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3 &ldquo;<B>Award</B>&rdquo;
means an award of a Stock Option, Stock Appreciation Right, Restricted Stock, Restricted Stock Unit, Performance Share, Performance Unit,
Incentive Bonus Award, Other Cash-Based Award and/or Other Stock-Based Award granted under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.4 &ldquo;<B>Award Agreement</B>&rdquo;
means either (i) a written or electronic agreement entered into between the Company and a Participant setting forth the terms and conditions
of an Award, including any amendment or modification thereof, or (ii) a written or electronic statement issued by the Company to a Participant
describing the terms and provisions of such Award, including any amendment or modification thereof. The Committee may provide for the
use of electronic, internet or other non-paper Award Agreements, and the use of electronic, internet or other non-paper means for the
acceptance thereof and actions thereunder by a Participant. Each Award Agreement shall be subject to the terms and conditions of the Plan
and need not be identical.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.5 &ldquo;<B>Board</B>&rdquo;
means the Board of Directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.6 &ldquo;<B>Cause</B>&rdquo;
means a Participant&rsquo;s (i) conviction of, or the entry of a plea of guilty or no contest to, a felony or any other crime that causes
the Company or its Affiliates disgrace or disrepute, or materially and adversely affects the Company&rsquo;s or its Affiliates&rsquo;
operations or financial performance, (ii) gross negligence or willful misconduct with respect to the Company or any of its Affiliates,
including, without limitation fraud, embezzlement, theft or proven dishonesty in the course of Awardee&rsquo;s employment or other service;
(iii) use of controlled drugs other than in accordance with a physician&rsquo;s prescription; (iv) refusal to perform any lawful, material
obligation or fulfill any duty (other than any duty or obligation of the type described in clause (vi) below) to the Company or its Affiliates
(other than due to a disability), which refusal, if curable, is not cured within fifteen (15) days after delivery of written notice thereof;
(v) material breach of any agreement with or duty owed to the Company or any of its Affiliates, which breach, if curable, is not cured
within fifteen (15) days after the delivery of written notice thereof; (vi) any breach of any obligation or duty to the Company or any
of its Affiliates (whether arising by statute, common law or agreement) relating to confidentiality, noncompetition, nonsolicitation or
proprietary rights; or (vii) any material breach of any policy of the Company or its Affiliates or any action that the Board, in its sole
discretion, determines is reasonably likely to cause the Company or its Affiliates disgrace or disrepute. Notwithstanding the foregoing,
if a Participant and the Company (or any of its Affiliates) have entered into an employment agreement, consulting agreement or other similar
agreement that specifically defines &ldquo;cause,&rdquo; then with respect to such Participant, &ldquo;Cause&rdquo; shall have the meaning
defined in that employment agreement, consulting agreement or other agreement.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.7 &ldquo;<B>Change in Control</B>&rdquo;
shall be deemed to have occurred if any one of the following events shall occur:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) Any Person becomes
the beneficial owner (as defined in Rule 13(d)-3 under the Exchange Act) of shares of Common Stock representing more than 50% of the total
number of votes that may be cast for the election of directors of the Company; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) The consummation
of any (a) merger or other business combination of the Company, (b) sale of all or substantially all of the Company&rsquo;s assets or
(c) combination of the foregoing transactions (a &ldquo;<B>Transaction</B>&rdquo;), other than a Transaction involving only the Company
and one or more of its subsidiaries, or a Transaction immediately following which the shareholders of the Company immediately prior to
the Transaction continue to have a majority of the voting power in the resulting entity or a parent entity; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii) Within any
twelve (12)-month period beginning on or after the Effective Date, the persons who were directors of the Company immediately before the
beginning of such period (the &ldquo;<B>Incumbent Directors</B>&rdquo;) shall cease (for any reason other than death) to constitute at
least a majority of the Board (or the board of directors of any successor to the Company); provided that any director who was not a director
as of the date hereof shall be deemed to be an Incumbent Director if such director was elected to the Board by, or on the recommendation
of or with the approval of, at least two-thirds of the directors who then qualified as Incumbent Directors either actually or by prior
operation of the foregoing unless such election, recommendation or approval was the result of an actual or threatened election contest
of the type contemplated by Rule 14a-11 promulgated under the Exchange Act or any successor provision; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv) The shareholders
of the Company approve a plan of complete liquidation or dissolution of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the foregoing,
(1) no event or condition shall constitute a Change in Control to the extent that, if it were, a penalty tax would be imposed under Section
409A of the Code; provided that, in such a case, the event or condition shall continue to constitute a Change in Control to the maximum
extent possible (e.g., if applicable, in respect of vesting without an acceleration of distribution) without causing the imposition of
such penalty tax and (2) no Change in Control shall be deemed to have occurred, and no rights arising upon a Change in Control as provided
in the Plan or any Award Agreement shall exist, to the extent that the Board so determines by resolution adopted and not rescinded prior
to the Change in Control; <I>provided, however</I>, that no such determination by the Board shall be effective if it would cause a Participant
to be subject to a penalty tax under Section 409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.8 &ldquo;<B>Code</B>&rdquo;
means the Internal Revenue Code of 1986, as amended. For purposes of this Plan, references to sections of the Code shall be deemed to
include references to any applicable regulations thereunder and any successor or similar provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.9 &ldquo;<B>Committee</B>&rdquo;
means the committee of the Board delegated with the authority to administer the Plan, or the full Board, as provided in Section 3 of the
Plan. With respect to any decision relating to a Reporting Person, the Committee shall consist solely of two or more directors who are
disinterested within the meaning of Rule 16b-3 promulgated under the Exchange Act, as amended from time to time, or any successor provision.
The fact that a Committee member shall fail to qualify under any of these requirements shall not invalidate an Award if the Award is otherwise
validly made under the Plan. The Board may at any time appoint additional members to the Committee, remove and replace members of the
Committee with or without cause, and fill vacancies on the Committee however caused.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.10 &ldquo;<B>Common Stock</B>&rdquo;
means the Company&rsquo;s Common Stock, par value $0.0001 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.11 &ldquo;<B>Company</B>&rdquo;
means Pasithea Therapeutics Corp., a Delaware corporation, and any successor thereto as provided in Section 15.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.12 &ldquo;<B>Continuous
Service</B>&rdquo; means that the Participant&rsquo;s service with the Company or an Affiliate, whether as an employee, director or consultant,
is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company or an Affiliate as
an employee, director or consultant or a change in the entity for which the Participant renders such service, provided that there is no
interruption or termination of the Participant&rsquo;s service with the Company or an Affiliate, will not terminate a Participant&rsquo;s
Continuous Service; provided, however, that if the entity for which a Participant is rendering services ceases to qualify as an Affiliate,
as determined by the Committee in its sole discretion, such Participant&rsquo;s Continuous Service will be considered to have terminated
on the date such entity ceases to qualify as an Affiliate. For example, a change in status from an employee of the Company to a consultant
of an Affiliate or to a director will not constitute an interruption of Continuous Service. To the extent permitted by Applicable Law,
the Committee or the chief executive officer of the Company, in that party&rsquo;s sole discretion, may determine whether Continuous Service
will be considered interrupted in the case of (i) any leave of absence approved by the Company or chief executive officer, including sick
leave, military leave or any other personal leave, or (ii) transfers between the Company, an Affiliate, or their successors. Notwithstanding
the foregoing, a leave of absence will be treated as Continuous Service for purposes of vesting in an Award only to such extent as may
be provided in the Company&rsquo;s (or an Affiliate&rsquo;s) leave of absence policy, in the written terms of any leave of absence agreement
or policy applicable to the Participant, or as otherwise required by Applicable Law or permitted by the Committee. Unless the Committee
provides otherwise, in its sole discretion, or as otherwise required by Applicable Law, vesting of Awards shall be tolled during any unpaid
leave of absence by a Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.13 &ldquo;<B>Control</B>&rdquo;
means, as to any Person, the power to direct or cause the direction of the management and policies of such Person, or the power to appoint
directors of the Company, whether through the ownership of voting securities, by contract or otherwise (the terms &ldquo;<B>Controlled
by</B>&rdquo; and &ldquo;<B>under common Control with</B>&rdquo; shall have correlative meanings).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.14 &ldquo;<B>Date of Grant</B>&rdquo;
means the date on which an Award under the Plan is granted by the Committee, or such later date as the Committee may specify to be the
effective date of an Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.15 &ldquo;<B>Disability</B>&rdquo;
means a Participant being considered &ldquo;disabled&rdquo; within the meaning of Section 409A of the Code and Treasury Regulation 1.409A-3(i)(4),
as well as any successor regulation or interpretation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.16 &ldquo;<B>Effective Date</B>&rdquo;
means the date set forth in Section 17.1 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.17 &ldquo;<B>Eligible Person</B>&rdquo;
means any person who is an employee, officer, director, consultant, advisor or other individual service provider of the Company or any
Subsidiary, or any person who is determined by the Committee to be a prospective employee, officer, director, consultant, advisor or other
individual service provider of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.18 &ldquo;<B>Exchange Act</B>&rdquo;
means the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.19 &ldquo;<B>Fair Market
Value</B>&rdquo; of a share of Common Stock shall be, as applied to a specific date (i) the closing price of a share of Common Stock as
of such date on the principal established stock exchange or national market system on which the Common Stock is then traded (or, if there
is no trading in the Common Stock as of such date, the closing price of a share of Common Stock on the most recent date preceding such
date on which trades of the Common Stock were recorded), or (ii) if the shares of Common Stock are not then traded on an established stock
exchange or national market system but are then traded in an over-the-counter market, the average of the closing bid and asked prices
for the shares of Common Stock in such over-the-counter market as of such date (or, if there are no closing bid and asked prices for the
shares of Common Stock as of such date, the average of the closing bid and the asked prices for the shares of Common Stock on the most
recent date preceding such date on which such closing bid and asked prices are available on such over-the-counter market), or (iii) if
the shares of Common Stock are not then listed on a national securities exchange or national market system or traded in an over-the-counter
market, the price of a share of Common Stock as determined by the Committee in its discretion in a manner consistent with Section 409A
of the Code and Treasury Regulation 1.409A-1(b)(5)(iv), as well as any successor regulation or interpretation.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.20 &ldquo;<B>Incentive Bonus
Award</B>&rdquo; means an Award granted under Section 12 of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.21 &ldquo;<B>Incentive Stock
Option</B>&rdquo; means a Stock Option granted under Section 6 hereof that is intended to meet the requirements of Section 422 of the
Code and the regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.22 &ldquo;<B>Nonqualified
Stock Option</B>&rdquo; means a Stock Option granted under Section 6 hereof that is not an Incentive Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.23 &ldquo;<B>Other Cash-Based
Award</B>&rdquo; means a contractual right granted to an Eligible Person under Section 13 hereof entitling such Eligible Person to receive
a cash payment at such times, and subject to such conditions, as are set forth in the Plan and the applicable Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.24 &ldquo;<B>Other Stock-Based
Award</B>&rdquo; means a contractual right granted to an Eligible Person under Section 13 representing a notional unit interest equal
in value to a share of Common Stock to be paid and distributed at such times, and subject to such conditions as are set forth in the Plan
and the applicable Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.25 &ldquo;<B>Outside Director</B>&rdquo;
means a director of the Board who is not an employee of the Company or a Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.26 &ldquo;<B>Participant</B>&rdquo;
means any Eligible Person who holds an outstanding Award under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.27 &ldquo;<B>Person</B>&rdquo;
shall mean, unless otherwise provided, any individual, partnership, firm, trust, corporation, limited liability company or other similar
entity. When two or more Persons act as a partnership, limited partnership, syndicate or other group for the purpose of acquiring, holding
or disposing of Common Stock, such partnership, limited partnership, syndicate or group shall be deemed a &ldquo;Person&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.28 &ldquo;<B>Performance
Goals</B>&rdquo; shall mean performance goals established by the Committee as contingencies for the grant, exercise, vesting, distribution,
payment and/or settlement, as applicable, of Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.29 &ldquo;<B>Performance
Shares</B>&rdquo; means a contractual right granted to an Eligible Person under Section 10 hereof representing a notional unit interest
equal in value to a share of Common Stock to be paid and distributed at such times, and subject to such conditions, as are set forth in
the Plan and the applicable Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.30 &ldquo;<B>Performance
Unit</B>&rdquo; means a contractual right granted to an Eligible Person under Section 11 hereof representing a notional dollar interest
as determined by the Committee to be paid and distributed at such times, and subject to such conditions, as are set forth in the Plan
and the applicable Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.31 &ldquo;<B>Plan</B>&rdquo;
means this Pasithea Therapeutics Corp. 2023 Stock Incentive Plan, as it may be amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.32 &ldquo;<B>Reporting Person</B>&rdquo;
means an officer, director or greater than ten (10) percent stockholder of the Company within the meaning of Rule 16a-2 under the Exchange
Act, who is required to file reports pursuant to Rule 16a-3 under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.33 &ldquo;<B>Restricted
Stock Award</B>&rdquo; means a grant of shares of Common Stock to an Eligible Person under Section 8 hereof that are issued subject to
such vesting and transfer restrictions and such other conditions as are set forth in the Plan and the applicable Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.34 &ldquo;<B>Restricted
Stock Unit Award</B>&rdquo; means a contractual right granted to an Eligible Person under Section 9 hereof representing notional unit
interests equal in value to a share of Common Stock to be paid and distributed at such times, and subject to such conditions, as are set
forth in the Plan and the applicable Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.35 &ldquo;<B>Securities
Act</B>&rdquo; means the Securities Act of 1933, as amended.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.36 &ldquo;<B>Stock Appreciation
Right</B>&rdquo; or &ldquo;<B>SAR</B>&rdquo; means a contractual right granted to an Eligible Person under Section 7 hereof entitling
such Eligible Person to receive a payment, upon the exercise of such right, in such amount and at such time, and subject to such conditions,
as are set forth in the Plan and the applicable Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.37 &ldquo;<B>Stock Option</B>&rdquo;
means a contractual right granted to an Eligible Person under Section 6 hereof to purchase shares of Common Stock at such time and price,
and subject to such conditions, as are set forth in the Plan and the applicable Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.38 &ldquo;<B>Subsidiary</B>&rdquo;
means an entity (whether or not a corporation) that is wholly or majority owned or controlled, directly or indirectly, by the Company;
provided, however, that with respect to Incentive Stock Options, the term &ldquo;Subsidiary&rdquo; shall include only an entity that qualifies
under section 424(f) of the Code as a &ldquo;subsidiary corporation&rdquo; with respect to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Administration</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1 <U>Committee Members.</U>
The Plan shall be administered by the Committee; provided that the entire Board may act in lieu of the Committee on any matter, subject
to Section 16b-3 Award requirements referred to in Section 2.9 of the Plan. If and to the extent permitted by Applicable Law, the Committee
may authorize one or more Reporting Persons (or other officers) to make Awards to Eligible Persons who are not Reporting Persons (or other
officers whom the Committee has specifically authorized to make Awards). Subject to Applicable Law and the restrictions set forth in the
Plan, the Committee may delegate administrative functions to individuals who are Reporting Persons, officers, or employees of the Company
or its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2 <U>Committee Authority.</U>
The Committee shall have such powers and authority as may be necessary or appropriate for the Committee to carry out its functions as
described in the Plan. Subject to the express limitations of the Plan, the Committee shall have authority in its discretion to determine
the Eligible Persons to whom, and the time or times at which, Awards may be granted, the number of shares, units or other rights subject
to each Award, the exercise, base or purchase price of an Award (if any), the time or times at which an Award will become vested, exercisable
or payable, the performance criteria, performance goals and other conditions of an Award, the duration of the Award, and all other terms
of the Award. Subject to the terms of the Plan, the Committee shall have authority to amend the terms of an Award in any manner that is
not inconsistent with the Plan (including without limitation to determine, add, cancel, waive, amend or otherwise alter any restrictions,
terms or conditions of any Award, or extend the post-termination exercisability period of any Stock Option and/or Stock Appreciation Right);
provided that neither the Board nor the Committee may, without shareholder approval, reduce or reprice the exercise price of any Stock
Option and/or Stock Appreciation Right that exceeds the Fair Market Value of a share of Common Stock on the date of such repricing; and
provided further that no such action shall adversely affect the rights of a Participant with respect to an outstanding Award without the
Participant&rsquo;s consent. The Committee shall also have discretionary authority to interpret the Plan, to make all factual determinations
under the Plan, and to make all other determinations necessary or advisable for Plan administration, including, without limitation, to
correct any defect, to supply any omission or to reconcile any inconsistency in the Plan or any Award Agreement. The Committee may prescribe,
amend, and rescind rules and regulations relating to the Plan. The Committee&rsquo;s determinations under the Plan need not be uniform
and may be made by the Committee selectively among Participants and Eligible Persons, whether or not such persons are similarly situated.
The Committee shall, in its discretion, consider such factors as it deems relevant in making its interpretations, determinations and actions
under the Plan including, without limitation, the recommendations or advice of any officer or employee of the Company or such attorneys,
consultants, accountants or other advisors as it may select. All interpretations, determinations, and actions by the Committee shall be
final, conclusive, and binding upon all parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.3 <U>No Liability; Indemnification</U>.
Neither the Board nor any Committee member, nor any Person acting at the direction of the Board or the Committee, shall be liable for
any act, omission, interpretation, construction or determination made in good faith with respect to the Plan or any Award or Award Agreement.
The Company and its Subsidiaries shall pay or reimburse any member of the Committee, as well as any other Person who takes action on behalf
of the Plan, for all reasonable expenses incurred with respect to the Plan, and to the full extent allowable under Applicable Law shall
indemnify each and every one of them for any claims, liabilities, and costs (including reasonable attorney&rsquo;s fees) arising out of
their good faith performance of duties on behalf of the Company with respect to the Plan. The Company and its Subsidiaries may, but shall
not be required to, obtain liability insurance for this purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Shares Subject to the Plan</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1 <U>Plan Share Limitation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) Subject to adjustment
pursuant to Section 4.2 and any other applicable provisions hereof, the maximum aggregate number of shares of Common Stock which may be
issued under all Awards granted to Participants under the Plan initially shall be (i) 2,500,000 shares plus (ii) such number of unused
shares of Common Stock reserved under the Pasithea Therapeutics Corp. 2021 Stock Incentive Plan (the &ldquo;<B>2021 Plan</B>&rdquo;) as
of the Effective Date, which unused reserve shall be rolled into this Plan (subsections (i) and (ii) together, the &ldquo;<B>Share Reserve</B>&rdquo;);
all of which shares may, but need not, be issued in respect of Incentive Stock Options. In addition, there shall be rolled into this Plan
and added to the Share Reserve (but not issued in respect of Incentive Stock Options) such number of shares of Common Stock as become
available for issuance under the Plan in accordance with Section 4.1(d) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) The number of
shares of Common Stock available for issuance under the Plan shall automatically increase on January 1st of each year commencing with
January 1, 2024 and on each January 1 thereafter until the Expiration Date (as defined in Section 17.2 of the Plan), in an amount equal
to three percent (3%) of the total number of shares of Common Stock outstanding on December 31st of the preceding calendar year. Notwithstanding
the foregoing, the Board may act prior to the first day of any calendar year, to provide that there shall be no increase in the share
reserve for such calendar year or that the increase in the share reserve for such calendar year shall be a lesser number of shares of
Common Stock than would otherwise occur pursuant to the preceding sentence. For avoidance of doubt, none of the additional shares of Common
Stock available for issuance pursuant to this Section 4.1(b) shall be issued in respect of Incentive Stock Options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) Shares of Common
Stock issued under the Plan may be either authorized but unissued shares or shares held in the Company&rsquo;s treasury. To the extent
that any Award payable in shares of Common Stock is forfeited, canceled, returned to the Company for failure to satisfy vesting requirements
or upon the occurrence of other forfeiture events, or otherwise terminates without payment being made thereunder, the shares of Common
Stock covered thereby will no longer be counted against the foregoing maximum share limitations and may again be made subject to Awards
under the Plan pursuant to such limitations. Awards settled in cash shall not count against the foregoing maximum share limitation. Shares
of Common Stock that otherwise would have been issued upon the exercise of a Stock Option or SAR or in payment with respect to any other
form of Award, but are surrendered in payment or partial payment of the exercise price thereof and/or taxes withheld with respect to the
exercise thereof or the making of such payment, will no longer be counted against the foregoing maximum share limitations and may again
be made subject to Awards under the Plan pursuant to such limitations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) To the extent
that any award under the 2021 Plan payable in shares of Common Stock is forfeited, cancelled, returned to or repurchased by the Company
for failure to satisfy vesting requirements or upon the occurrence of other forfeiture events, or otherwise terminates without payment
being made thereunder, the shares of Common Stock covered thereby shall be available for issuance under this Plan. Shares of Common Stock
that otherwise would have been issued under the 2021 Plan upon the exercise of a stock option or in payment with respect to any other
form of award under the 2021 Plan, that are surrendered in payment or partial payment of the exercise price thereof and/or taxes withheld
with respect to the exercise thereof or the making of such payment, shall also be available for issuance under this Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2 <U>Adjustments.</U> If
there shall occur any change with respect to the outstanding shares of Common Stock by reason of any recapitalization, reclassification,
stock dividend, extraordinary dividend, stock split, reverse stock split, or other distribution with respect to the shares of Common Stock,
or any merger, reorganization, consolidation, combination, spin-off or other similar corporate change, or any other change affecting the
Common Stock, the Committee shall, in the manner and to the extent that it deems appropriate and equitable to the Participants and consistent
with the terms of the Plan, cause an adjustment to be made in (i) the maximum numbers and kind of shares provided in Section 4.1 hereof,
(ii) the numbers and kind of shares of Common Stock, units, or other rights subject to then outstanding Awards, (iii) the price for each
share or unit or other right subject to then outstanding Awards, (iv) the performance measures or goals relating to the vesting of an
Award, and (v) any other terms of an Award that are affected by the event to prevent dilution or enlargement of a Participant&rsquo;s
rights under an Award. Notwithstanding the foregoing, in the case of Incentive Stock Options, any such adjustments shall, to the extent
practicable, be made in a manner consistent with the requirements of Section 424(a) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3 <U>Outside Director Limitation</U>.
Notwithstanding any provision to the contrary in the Plan, the Committee may establish total cash and equity compensation for non-employee
members of the Board from time to time, subject to the limitations in the Plan. The Committee will from time to time determine the terms,
conditions and amounts of all such non-employee director compensation in its discretion and pursuant to the exercise of its business judgment,
taking into account such factors, circumstances and considerations as it shall deem relevant from time to time, provided that the sum
of any cash compensation, or other compensation, and the value (determined as of the grant date in accordance with Financial Accounting
Standards Board Accounting Standards Codification Topic 718, or any successor thereto) of Awards granted to a non-employee member of the
Board as compensation for services as a non-employee member of the Board during any fiscal year of the Company may not exceed $500,000,
increased to $750,000 in the fiscal year in which the Effective Date occurs or in the fiscal year of a non-employee member of the Board&rsquo;s
initial service as a non-employee member of the Board. The Committee may make exceptions to this limit for individual non-employee members
of the Board in extraordinary circumstances, as the Committee may determine in its discretion, provided that the non-employee member of
the Board receiving such additional compensation may not participate in the decision to award such compensation or in other contemporaneous
compensation decisions involving non-employee members of the Board.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Participation and Awards</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1 <U>Designation of Participants.</U>
All Eligible Persons are eligible to be designated by the Committee to receive Awards and become Participants under the Plan. The Committee
has the authority, in its discretion, to determine and designate from time to time those Eligible Persons who are to be granted Awards,
the types of Awards to be granted and the number of shares of Common Stock or units subject to Awards granted under the Plan. In selecting
Eligible Persons to be Participants and in determining the type and amount of Awards to be granted under the Plan, the Committee shall
consider any and all factors that it deems relevant or appropriate.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2 <U>Determination of Awards.</U>
The Committee shall determine the terms and conditions of all Awards granted to Participants in accordance with its authority under Section
3.2 hereof. An Award may consist of one type of right or benefit hereunder or of two or more such rights or benefits granted in tandem
or in the alternative. To the extent deemed appropriate by the Committee, an Award shall be evidenced by an Award Agreement as described
in Section 15.1 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock Options</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.1 <U>Grant of Stock Option.</U>
A Stock Option may be granted to any Eligible Person selected by the Committee. Subject to the provisions of Section 6.6 hereof and Section
422 of the Code, each Stock Option shall be designated, in the sole discretion of the Committee, as an Incentive Stock Option or as a
Nonqualified Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.2 <U>Exercise Price.</U>
The exercise price per share of a Stock Option shall not be less than 100% of the Fair Market Value of a share of Common Stock on the
Date of Grant, subject to adjustments as provided for under Section 4.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.3 <U>Vesting of Stock Options.</U>
The Committee shall in its sole discretion prescribe the time or times at which, or the conditions upon which, a Stock Option or portion
thereof shall become vested and/or exercisable. Unless otherwise provided by the Committee, no Stock Option shall provide for vesting
or exercise earlier than one year after the Date of Grant. The requirements for vesting and exercisability of a Stock Option may be based
on the Continuous Service of the Participant for a specified time period (or periods) and/or on the attainment of a specified performance
goal (or goals) established by the Committee in its discretion. The Committee may, in its sole discretion, accelerate the vesting or exercisability
of any Stock Option at any time. The Committee, in its sole discretion, may allow a Participant to exercise unvested Nonqualified Stock
Options, in which case the shares of Common Stock then issued shall be Restricted Stock having analogous vesting restrictions to the unvested
Nonqualified Stock Options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.4 <U>Term of Stock Options.</U>
The Committee shall in its discretion prescribe in an Award Agreement the period during which a vested Stock Option may be exercised,
provided that the maximum term of a Stock Option shall be ten (10) years from the Date of Grant. A Stock Option may be earlier terminated
as specified by the Committee and set forth in an Award Agreement upon or following the termination of a Participant&rsquo;s Continuous
Service for any reason, including by reason of voluntary resignation, death, Disability, termination for Cause or any other reason. Except
as otherwise provided in this Section 6 or in an Award Agreement as such agreement may be amended from time to time upon authorization
of the Committee, no Stock Option may be exercised at any time during the term thereof unless the Participant is then in Continuous Service.
Notwithstanding the foregoing, unless an Award Agreement provides otherwise:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) If a Participant&rsquo;s
Continuous Service terminates by reason of his or her death, any Stock Option held by such Participant may, to the extent then exercisable,
be exercised by such Participant&rsquo;s estate or any Person who acquires the right to exercise such Stock Option by bequest or inheritance
at any time in accordance with its terms for up to one (1) year after the date of such Participant&rsquo;s death (but in no event after
the earlier of the expiration of the term of such Stock Option or such time as the Stock Option is otherwise canceled or terminated in
accordance with its terms). Upon expiration of such one-year period, no portion of the Stock Option held by such Participant shall be
exercisable and the Stock Option shall be deemed to be canceled, forfeited and of no further force or effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) If a Participant&rsquo;s
Continuous Service terminates by reason of his or her Disability, any Stock Option held by such Participant may, to the extent then exercisable,
be exercised by the Participant or his or her personal representative at any time in accordance with its terms for up to one (1) year
after the date of such Participant&rsquo;s termination of Continuous Service (but in no event after the earlier of the expiration of the
term of such Stock Option or such time as the Stock Option is otherwise canceled or terminated in accordance with its terms). Upon expiration
of such one-year period, no portion of the Stock Option held by such Participant shall be exercisable and the Stock Option shall be deemed
to be canceled, forfeited and of no further force or effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) If a Participant&rsquo;s
Continuous Service terminates for any reason other than death, Disability or Cause, any Stock Option held by such Participant may, to
the extent then exercisable, be exercised by the Participant up until ninety (90) days following such termination of Continuous Service
(but in no event after the earlier of the expiration of the term of such Stock Option or such time as the Stock Option is otherwise canceled
or terminated in accordance with its terms). Upon expiration of such 90-day period, no portion of the Stock Option held by such Participant
shall be exercisable and the Stock Option shall be deemed to be canceled, forfeited and of no further force or effect.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) To the extent
that a Stock Option of a Participant whose Continuous Service terminates is not exercisable, such Stock Option shall be deemed forfeited
and canceled on the ninetieth (90<SUP>th</SUP>) day after such termination of Continuous Service or at such earlier time as the Committee
may determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.5 <U>Stock Option Exercise.</U>
Subject to such terms and conditions as shall be specified in an Award Agreement, a Stock Option may be exercised in whole or in part
at any time during the term thereof by notice in the form required by the Company, and payment of the aggregate exercise price by certified
or bank check, or such other means as the Committee may accept. As set forth in an Award Agreement or otherwise determined by the Committee,
in its sole discretion, at or after grant, payment in full or in part of the exercise price of an Option may be made: (i) in the form
of shares of Common Stock that have been held by the Participant for such period as the Committee may deem appropriate for accounting
purposes or otherwise, valued at the Fair Market Value of such shares on the date of exercise; (ii) by surrendering to the Company shares
of Common Stock otherwise receivable on exercise of the Option; (iii) by a cashless exercise program implemented by the Committee in connection
with the Plan; (iv) subject to the approval of the Committee, by a full recourse, interest bearing promissory note having such terms as
the Committee may, in its sole discretion, permit and/or (v) by such other method as may be approved by the Committee and set forth in
an Award Agreement. Subject to any governing rules or regulations, as soon as practicable after receipt of written notification of exercise
and full payment of the exercise price and satisfaction of any applicable tax withholding pursuant to Section 16.5, the Company shall
deliver to the Participant evidence of book entry shares of Common Stock, or upon the Participant&rsquo;s request, Common Stock certificates
in an appropriate amount based upon the number of shares of Common Stock purchased under the Option. Unless otherwise determined by the
Committee, all payments under all of the methods indicated above shall be paid in United States dollars or shares of Common Stock, as
applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.6 <U>Additional Rules for
Incentive Stock Options</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) <U>Eligibility</U>.
An Incentive Stock Option may only be granted to an Eligible Person who is considered an employee under Treasury Regulation &sect;1.421-1(h)
of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) <U>Annual Limits</U>.
No Incentive Stock Option shall be granted to an Eligible Person as a result of which the aggregate Fair Market Value (determined as of
the Date of Grant) of the stock with respect to which Incentive Stock Options are exercisable for the first time in any calendar year
under the Plan and any other stock option plans of the Company or any Subsidiary would exceed $100,000, determined in accordance with
Section 422(d) of the Code. This limitation shall be applied by taking Incentive Stock Options into account in the order in which granted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) <U>Ten Percent
Stockholders</U>. If a Stock Option granted under the Plan is intended to be an Incentive Stock Option, and if the Participant, at the
time of grant, owns stock possessing ten percent (10%) or more of the total combined voting power of all classes of Common Stock of the
Company or any Subsidiary, then (i) the Stock Option exercise price per share shall in no event be less than 110% of the Fair Market Value
of the Common Stock on the date of such grant and (ii) such Stock Option shall not be exercisable after the expiration of five (5) years
following the date such Stock Option is granted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) <U>Termination
of Employment</U>. An Award of an Incentive Stock Option shall provide that such Stock Option may be exercised not later than three (3)
months following termination of employment of the Participant with the Company and all Subsidiaries, or not later than one (1) year following
death or a permanent and total disability within the meaning of Section 22(e)(3) of the Code, as and to the extent determined by the Committee
to be necessary to comply with the requirements of Section 422 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) <U>Disqualifying
Dispositions</U>. If shares of Common Stock acquired by exercise of an Incentive Stock Option are disposed of within two (2) years following
the Date of Grant or one (1) year following the transfer of such shares to the Participant upon exercise, the Participant shall, promptly
following such disposition, notify the Company in writing of the date and terms of such disposition and provide such other information
regarding the disposition as the Company may reasonably require.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock Appreciation Rights</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.1 <U>Grant of Stock Appreciation
Rights.</U> A Stock Appreciation Right may be granted to any Eligible Person selected by the Committee. Stock Appreciation Rights may
be granted on a basis that allows for the exercise of the right by the Participant or that provides for the automatic payment of the right
upon a specified date or event.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.2 <U>Base Price</U>. The
base price of a Stock Appreciation Right shall be determined by the Committee in its sole discretion; provided, however, that the base
price for any grant of a Stock Appreciation Right shall not be less than 100% of the Fair Market Value of a share of Common Stock on the
Date of Grant, subject to adjustments as provided for under Section 4.2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.3 <U>Vesting Stock Appreciation
Rights</U>. The Committee shall in its discretion prescribe the time or times at which, or the conditions upon which, a Stock Appreciation
Right or portion thereof shall become vested and/or exercisable. Unless otherwise provided by the Committee, no Stock Appreciation Right
shall provide for vesting or exercise earlier than one (1) year after the Date of Grant. The requirements for vesting and exercisability
of a Stock Appreciation Right may be based on the Continuous Service of a Participant for a specified time period (or periods) or on the
attainment of a specified performance goal (or goals) established by the Committee in its discretion. The Committee may, in its sole discretion,
accelerate the vesting or exercisability of any Stock Appreciation Right at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.4 <U>Term of Stock Appreciation
Rights</U>. The Committee shall in its discretion prescribe in an Award Agreement the period during which a vested Stock Appreciation
Right may be exercised, provided that the maximum term of a Stock Appreciation Right shall be ten (10) years from the Date of Grant. A
Stock Appreciation Right may be earlier terminated as specified by the Committee and set forth in an Award Agreement upon or following
the termination of a Participant&rsquo;s Continuous Service for any reason, including by reason of voluntary resignation, death, Disability,
termination for Cause or any other reason. Except as otherwise provided in this Section 7 or in an Award Agreement, as such agreement
may be amended from time to time upon authorization of the Committee, no Stock Appreciation Right may be exercised at any time during
the term thereof unless the Participant is then in Continuous Service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.5 <U>Payment of Stock Appreciation
Rights</U>. Subject to such terms and conditions as shall be specified in an Award Agreement, a vested Stock Appreciation Right may be
exercised in whole or in part at any time during the term thereof by notice in the form required by the Company and payment of any exercise
price. Upon the exercise of a Stock Appreciation Right and payment of any applicable exercise price, a Participant shall be entitled to
receive an amount determined by multiplying: (i) the excess of the Fair Market Value of a share of Common Stock on the date of exercise
of the Stock Appreciation Right over the base price of such Stock Appreciation Right, by (ii) the number of shares as to which such Stock
Appreciation Right is exercised. Payment of the amount determined under the immediately preceding sentence may be made, as approved by
the Committee and set forth in the Award Agreement, in shares of Common Stock valued at their Fair Market Value on the date of exercise,
in cash, or in a combination of shares of Common Stock and cash, subject to applicable tax withholding requirements set forth in Section
16.5. If Stock Appreciation Rights are settled in shares of Common Stock, then as soon as practicable following the date of settlement
the Company shall deliver to the Participant evidence of book entry shares of Common Stock, or upon the Participant&rsquo;s request, Common
Stock certificates in an appropriate amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restricted Stock Awards</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.1 <U>Grant of Restricted
Stock Awards</U>. A Restricted Stock Award may be granted to any Eligible Person selected by the Committee. The Committee may require
the payment by the Participant of a specified purchase price in connection with any Restricted Stock Award. The Committee may provide
in an Award Agreement for the payment of dividends and distributions to the Participant at such times as paid to stockholders generally
or at the times of vesting or other payment of the Restricted Stock Award. If any dividends or distributions are paid in stock while a
Restricted Stock Award is subject to restrictions under Section 8.3 of the Plan, the dividends or other distributions shares shall be
subject to the same restrictions on transferability as the shares of Common Stock to which they were paid unless otherwise set forth in
the Award Agreement. The Committee may also subject the grant of any Restricted Stock Award to the execution of a voting agreement with
the Company or with any Affiliate of the Company.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.2 <U>Vesting Requirements</U>.
The restrictions imposed on shares of Common Stock granted under a Restricted Stock Award shall lapse in accordance with the vesting requirements
specified by the Committee in the Award Agreement. Unless otherwise provided by the Committee, no Restricted Stock Award shall provide
for vesting earlier than one (1) year after the Date of Grant. Upon vesting of a Restricted Stock Award, such Award shall be subject to
the tax withholding requirement set forth in Section 16.5. The requirements for vesting of a Restricted Stock Award may be based on the
Continuous Service of the Participant for a specified time period (or periods) or on the attainment of a specified performance goal (or
goals) established by the Committee in its discretion. The Committee may, in its sole discretion, accelerate the vesting of a Restricted
Stock Award at any time. If the vesting requirements of a Restricted Stock Award shall not be satisfied, the Award shall be forfeited
and the shares of Common Stock subject to the Award shall be returned to the Company. In the event that the Participant paid any purchase
price with respect to such forfeited shares, unless otherwise provided by the Committee in an Award Agreement, the Company will refund
to the Participant the lesser of (i) such purchase price and (ii) the Fair Market Value of such shares on the date of forfeiture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.3 <U>Restrictions</U>. Shares
granted under any Restricted Stock Award may not be transferred, assigned or subject to any encumbrance, pledge, or charge until all applicable
restrictions are removed or have expired, unless otherwise allowed by the Committee. The Committee may require in an Award Agreement that
certificates representing the shares granted under a Restricted Stock Award bear a legend making appropriate reference to the restrictions
imposed, and that certificates representing the shares granted or sold under a Restricted Stock Award will remain in the physical custody
of an escrow holder until all restrictions are removed or have expired.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.4 <U>Rights as Stockholder</U>.
Subject to the foregoing provisions of this Section 8 and the applicable Award Agreement, the Participant to whom a Restricted Stock Award
is made shall have all rights of a stockholder with respect to the shares granted to the Participant under the Restricted Stock Award,
including the right to vote the shares and receive all dividends and other distributions paid or made with respect thereto, unless the
Committee determines otherwise at the time the Restricted Stock Award is granted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.5 <U>Section 83(b) Election.</U>
If a Participant makes an election pursuant to Section 83(b) of the Code with respect to a Restricted Stock Award, the Participant shall
file, within thirty (30) days following the Date of Grant, a copy of such election with the Company (directed to the Secretary thereof)
and with the Internal Revenue Service, in accordance with the regulations under Section 83 of the Code. The Committee may provide in an
Award Agreement that the Restricted Stock Award is conditioned upon the Participant&rsquo;s making or refraining from making an election
with respect to the Award under Section 83(b) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restricted Stock Unit Awards</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.1 <U>Grant of Restricted
Stock Unit Awards</U>. A Restricted Stock Unit Award may be granted to any Eligible Person selected by the Committee. The value of each
stock unit under a Restricted Stock Unit Award is equal to the Fair Market Value of the Common Stock on the applicable date or time period
of determination, as specified by the Committee. A Restricted Stock Unit Award shall be subject to such restrictions and conditions as
the Committee shall determine. A Restricted Stock Unit Award may be granted together with a dividend equivalent right with respect to
the shares of Common Stock subject to the Award, which may be accumulated and may be deemed reinvested in additional stock units, as determined
by the Committee in its sole discretion. If any dividend equivalents are paid while a Restricted Stock Unit Award is subject to restrictions
under Section 9 of the Plan, the Committee may, in its sole discretion, provide in the Award Agreement for such dividend equivalents to
immediately be paid to the Participant holding such Restricted Stock Unit Award or pay such dividend equivalents subject to the same restrictions
on transferability as the Restricted Stock Units to which they relate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.2 <U>Vesting of Restricted
Stock Unit Awards</U>. On the Date of Grant, the Committee shall, in its discretion, determine any vesting requirements with respect to
a Restricted Stock Unit Award, which shall be set forth in the Award Agreement. The requirements for vesting of a Restricted Stock Unit
Award may be based on the Continuous Service of the Participant for a specified time period (or periods) or on the attainment of a specified
performance goal (or goals) established by the Committee in its discretion. Unless otherwise provided by the Committee, no Restricted
Stock Unit shall provide for vesting earlier than one (1) year after the Date of Grant. The Committee may, in its sole discretion, accelerate
the vesting of a Restricted Stock Unit Award at any time. A Restricted Stock Unit Award may also be granted on a fully vested basis, with
a deferred payment date as may be determined by the Committee or elected by the Participant in accordance with rules established by the
Committee and in compliance with Applicable Law including Section 409A of the Code.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.3 <U>Payment of Restricted
Stock Unit Awards</U>. A Restricted Stock Unit Award shall become payable to a Participant at the time or times determined by the Committee
and set forth in the Award Agreement, which may be upon or following the vesting of the Award. Payment of a Restricted Stock Unit Award
may be made, at the discretion of the Committee, in cash or in shares of Common Stock, or in a combination thereof as described in the
Award Agreement, subject to applicable tax withholding requirements set forth in Section 16.5. Any cash payment of a Restricted Stock
Unit Award shall be made based upon the Fair Market Value of the Common Stock, determined on such date or over such time period as determined
by the Committee. Notwithstanding the foregoing, unless specified otherwise in the Award Agreement, any Restricted Stock Unit, whether
settled in Common Stock or cash, shall be paid no later than two and one-half (2 &frac12;) months after the later of the calendar year
or fiscal year in which the Restricted Stock Units vest. If Restricted Stock Unit Awards are settled in shares of Common Stock, then as
soon as practicable following the date of settlement, the Company shall deliver to the Participant evidence of book entry shares of Common
Stock, or upon the Participant&rsquo;s request, Common Stock certificates in an appropriate amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Performance Shares</U>.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.1 <U>Grant of Performance
Shares</U>. Performance Shares may be granted to any Eligible Person other than an Outside Director selected by the Committee. A Performance
Share Award shall be subject to such restrictions and condition as the Committee shall specify. A Performance Share Award may be granted
with a dividend equivalent right with respect to the shares of Common Stock subject to the Award, which may be accumulated and may be
deemed reinvested in additional stock units, as determined by the Committee in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.2 <U>Value of Performance
Shares</U>. Each Performance Share shall have an initial value equal to the Fair Market Value of a Share on the Date of Grant. The Committee
shall set performance goals in its discretion that, depending on the extent to which they are met over a specified time period, shall
determine the number of Performance Shares that shall be paid to a Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.3 <U>Earning of Performance
Shares</U>. After the applicable time period has ended, the number of Performance Shares earned by the Participant over such time period
shall be determined as a function of the extent to which the applicable corresponding performance goals have been achieved. This determination
shall be made solely by the Committee. The Committee may, in its sole discretion, waive any performance or vesting conditions relating
to a Performance Share Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.4 <U>Form and Timing of
Payment of Performance Shares</U>. The Committee shall pay at the close of the applicable Performance Period, or as soon as practicable
thereafter, any earned Performance Shares in the form of cash or in shares of Common Stock or in a combination thereof, as specified in
a Participant&rsquo;s Award Agreement, subject to applicable tax withholding requirements set forth in Section 16.5. Notwithstanding the
foregoing, unless specified otherwise in the Award Agreement, all Performance Shares shall be paid no later than two and one-half (2 &frac12;)
months following the later of the calendar year or fiscal year in which such Performance Shares vest. Any shares of Common Stock paid
to a Participant under this Section 10.4 may be subject to any restrictions deemed appropriate by the Committee. If Performance Shares
are settled in shares of Common Stock, then as soon as practicable following the date of settlement the Company shall deliver to the Participant
evidence of book entry shares of Common Stock, or upon the Participant&rsquo;s request, Common Stock certificates in an appropriate amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Performance Units</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.1 <U>Grant of Performance
Units</U>. Performance Units may be granted to any Eligible Person other than an Outside Director selected by the Committee. A Performance
Unit Award shall be subject to such restrictions and condition as the Committee shall specify in a Participant&rsquo;s Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.2 <U>Value of Performance
Units</U>. Each Performance Unit shall have an initial notional value equal to a dollar amount determined by the Committee, in its sole
discretion. The Committee shall set performance goals in its discretion that, depending on the extent to which they are met over a specified
time period, will determine the number of Performance Units that shall be settled and paid to the Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.3 <U>Earning of Performance
Units</U>. After the applicable time period has ended, the number of Performance Units earned by the Participant, and the amount payable
in cash, in shares or in a combination thereof, over such time period shall be determined as a function of the extent to which the applicable
corresponding performance goals have been achieved. This determination shall be made solely by the Committee. The Committee may, in its
sole discretion, waive any performance or vesting conditions relating to a Performance Unit Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.4 <U>Form and Timing of
Payment of Performance Units</U>. The Committee shall pay at the close of the applicable Performance Period, or as soon as practicable
thereafter, any earned Performance Units in the form of cash or in shares of Common Stock or in a combination thereof, as specified in
a Participant&rsquo;s Award Agreement, subject to applicable tax withholding requirements set forth in Section 16.5. Notwithstanding the
foregoing, unless specified otherwise in the Award Agreement, all Performance Units shall be paid no later than two and one-half (2 &frac12;)
months following the later of the calendar year or fiscal year in which such Performance Units vest. Any shares of Common Stock paid to
a Participant under this Section 11.4 may be subject to any restrictions deemed appropriate by the Committee. If Performance Units are
settled in shares of Common Stock, then as soon as practicable following the date of settlement the Company shall deliver to the Participant
evidence of book entry shares of Common Stock, or upon the Participant&rsquo;s request, Common Stock certificates in an appropriate amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Incentive Bonus Awards</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.1 <U>Incentive Bonus Awards</U>.
The Committee, at its discretion, may grant Incentive Bonus Awards to such Participants as it may designate from time to time. The terms
of a Participant&rsquo;s Incentive Bonus Award shall be set forth in the Participant&rsquo;s Award Agreement. Each Award Agreement shall
specify such general terms and conditions as the Committee shall determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.2 <U>Incentive Bonus Award
Performance Criteria</U>. The determination of Incentive Bonus Awards for a given year or years may be based upon the attainment of specified
levels of Company or Subsidiary performance as measured by pre-established, objective performance criteria determined at the discretion
of the Committee. The Committee shall (i) select those Participants who shall be eligible to receive an Incentive Bonus Award, (ii) determine
the performance period, (iii) determine target levels of performance, and (iv) determine the level of Incentive Bonus Award to be paid
to each selected Participant upon the achievement of each performance level. The Committee generally shall make the foregoing determinations
prior to the commencement of services to which an Incentive Bonus Award relates, to the extent applicable, and while the outcome of the
performance goals and targets is uncertain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.3 <U>Payment of Incentive
Bonus Awards</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) Incentive Bonus
Awards shall be paid in cash or Common Stock, as set forth in a Participant&rsquo;s Award Agreement. Payments shall be made following
a determination by the Committee that the performance targets were attained and shall be made within two and one-half months after the
later of the end of the fiscal or calendar year in which the Incentive Award is no longer subject to a substantial risk of forfeiture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) The amount of
an Incentive Bonus Award to be paid upon the attainment of each targeted level of performance shall equal a percentage of a Participant&rsquo;s
base salary for the fiscal year, a fixed dollar amount, or such other formula, as determined by the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Other Cash-Based Awards and Other Stock-Based Awards</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.1 <U>Other Cash-Based and
Stock-Based Awards</U>. The Committee may grant other types of equity-based or equity-related Awards not otherwise described by the terms
of this Plan (including the grant or offer for sale of unrestricted Shares) in such amounts and subject to such terms and conditions,
as the Committee shall determine. Such Awards may involve the transfer of actual shares of Common Stock to a Participant, or payment in
cash or otherwise of amounts based on the value of shares of Common Stock. In addition, the Committee, at any time and from time to time,
may grant Other Cash-Based Awards to a Participant in such amounts and upon such terms as the Committee shall determine, in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.2 <U>Value of Cash-Based
Awards and Other Stock-Based Awards</U>. Each Other Stock-Based Award shall be expressed in terms of shares of Common Stock or units based
on shares of Common Stock, as determined by the Committee, in its sole discretion. Each Other Cash-Based Award shall specify a payment
amount or payment range as determined by the Committee, in its sole discretion. If the Committee exercises its discretion to establish
performance goals, the value of Other Cash-Based Awards that shall be paid to the Participant will depend on the extent to which such
performance goals are met.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.3 <U>Payment of Cash-Based
Awards and Other Stock-Based Awards</U>. Payment, if any, with respect to Other Cash-Based Awards and Other Stock-Based Award shall be
made in accordance with the terms of the Award, in cash or shares of Common Stock as the Committee determines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Change in Control</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">14.1 <U>Effect of a Change
in Control</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) The Committee
may, at the time of the grant of an Award and as set forth in an Award Agreement, provide for the effect of a &ldquo;Change in Control&rdquo;
on an Award. Such provisions may include any one or more of the following: (i) the acceleration or extension of time periods for purposes
of exercising, vesting in, or realizing gain from any Award, (ii) the elimination or modification of performance or other conditions related
to the payment or other rights under an Award, (iii) provision for the cash settlement of an Award for an equivalent cash value, as determined
by the Committee, or (iv) such other modification or adjustment to an Award as the Committee deems appropriate to maintain and protect
the rights and interests of Participants upon or following a Change in Control. To the extent necessary for compliance with Section 409A
of the Code, an Award Agreement shall provide that an Award subject to the requirements of Section 409A that would otherwise become payable
upon a Change in Control shall only become payable to the extent that the requirements for a &ldquo;change in control&rdquo; for purposes
of Section 409A have been satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) Notwithstanding
anything to the contrary set forth in the Plan, unless otherwise provided by an Award Agreement, upon or in anticipation of any Change
in Control, the Committee may, in its sole and absolute discretion and without the need for the consent of any Participant, take one or
more of the following actions contingent upon the occurrence of that Change in Control: (i) cause any or all outstanding Stock Options
and Stock Appreciation Rights held by Participants affected by the Change in Control to become vested and immediately exercisable, in
whole or in part; (ii) cause any or all outstanding Restricted Stock, Restricted Stock Units, Performance Shares, Performance Units, Incentive
Bonus Award and any other Award held by Participants affected by the Change in Control to become non-forfeitable, in whole or in part;
(iii) cancel any Stock Option or Stock Appreciation Right in exchange for a substitute option in a manner consistent with the requirements
of Treasury Regulation. &sect;1.424-1(a) or &sect;1.409A-1(b)(5)(v)(D), as applicable (notwithstanding the fact that the original Stock
Option may never have been intended to satisfy the requirements for treatment as an Incentive Stock Option); (iv) cancel any Restricted
Stock, Restricted Stock Units, Performance Shares or Performance Units held by a Participant in exchange for restricted stock or performance
shares of or stock or performance units in respect of the capital stock of any successor corporation; (v) redeem any Restricted Stock
held by a Participant affected by the Change in Control for cash and/or other substitute consideration with a value equal to the Fair
Market Value of an unrestricted share of Common Stock on the date of the Change in Control; (vi) terminate any Award in exchange for an
amount of cash and/or property equal to the amount, if any, that would have been attained upon the exercise of such Award or realization
of the Participant&rsquo;s rights as of the date of the occurrence of the Change in Control (the &ldquo;<B>Change in Control Consideration</B>&rdquo;);
provided, however that if the Change in Control Consideration with respect to any Option or Stock Appreciation Right does not exceed the
exercise price of such Option or Stock Appreciation Right, the Committee may cancel the Option or Stock Appreciation Right without payment
of any consideration therefor; and/or (vii) take any other action necessary or appropriate to carry out the terms of any definitive agreement
controlling the terms and conditions of the Change in Control. Any such Change in Control Consideration may be subject to any escrow,
indemnification and similar obligations, contingencies and encumbrances applicable in connection with the Change in Control to holders
of Common Stock. Without limitation of the foregoing, if as of the date of the occurrence of the Change in Control the Committee determines
that no amount would have been attained upon the realization of the Participant&rsquo;s rights, then such Award may be terminated by the
Company without payment. The Committee may cause the Change in Control Consideration to be subject to vesting conditions (whether or not
the same as the vesting conditions applicable to the Award prior to the Change in Control) and/or make such other modifications, adjustments
or amendments to outstanding Awards or this Plan as the Committee deems necessary or appropriate.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) The Committee
may require a Participant to (i) represent and warrant as to the unencumbered title to the Participant&rsquo;s Awards, (ii) bear such
Participant&rsquo;s pro rata share of any post-closing indemnity obligations, and be subject to the same or similar post-closing purchase
price adjustments, escrow terms, offset rights, holdback terms and similar conditions as the other holders of Common Stock, and (iii)
execute and deliver such documents and instruments as the Committee may reasonably require for the Participant to be bound by such obligations.
The Committee will endeavor to take action under this Section 14 in a manner that does not cause a violation of Section 409A of the Code
with respect to an Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>General Provisions</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.1 <U>Award Agreement</U>.
To the extent deemed necessary by the Committee, an Award under the Plan shall be evidenced by an Award Agreement in a written or electronic
form approved by the Committee setting forth the number of shares of Common Stock or units subject to the Award, the exercise price, base
price, or purchase price of the Award, the time or times at which an Award will become vested, exercisable or payable and the term of
the Award. The Award Agreement may also set forth the effect on an Award of termination of Continuous Service under certain circumstances.
The Award Agreement shall be subject to and incorporate, by reference or otherwise, all of the applicable terms and conditions of the
Plan, and may also set forth other terms and conditions applicable to the Award as determined by the Committee consistent with the limitations
of the Plan. Award Agreements evidencing Incentive Stock Options shall contain such terms and conditions as may be necessary to meet the
applicable provisions of Section 422 of the Code. The grant of an Award under the Plan shall not confer any rights upon the Participant
holding such Award other than such terms, and subject to such conditions, as are specified in the Plan as being applicable to such type
of Award (or to all Awards) or as are expressly set forth in the Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.2 <U>Forfeiture Events/Representations</U>.
The Committee may specify in an Award Agreement at the time of the Award that the Participant&rsquo;s rights, payments and benefits with
respect to an Award shall be subject to reduction, cancellation, forfeiture or recoupment upon the occurrence of certain specified events,
in addition to any otherwise applicable vesting or performance conditions of an Award. Such events shall include, but shall not be limited
to, termination of Continuous Service for Cause, violation of material Company policies, breach of noncompetition, confidentiality or
other restrictive covenants that may apply to the Participant, or other conduct by the Participant that is detrimental to the business
or reputation of the Company. The Committee may also specify in an Award Agreement that the Participant&rsquo;s rights, payments and benefits
with respect to an Award shall be conditioned upon the Participant making a representation regarding compliance with noncompetition, confidentiality
or other restrictive covenants that may apply to the Participant and providing that the Participant&rsquo;s rights, payments and benefits
with respect to an Award shall be subject to reduction, cancellation, forfeiture or recoupment on account of a breach of such representation.
Notwithstanding the foregoing, the confidentiality restrictions set forth in an Award Agreement shall not, and shall not be interpreted
to, impair a Participant from exercising any legally protected whistleblower rights (including under Rule 21 of the Exchange Act). In
addition and without limitation of the foregoing, any amounts paid hereunder shall be subject to recoupment in accordance with The Dodd&ndash;Frank
Wall Street Reform and Consumer Protection Act and any implementing regulations thereunder, any &ldquo;clawback&rdquo; policy adopted
by the Company or as is otherwise required by Applicable Law or stock exchange listing condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.3 <U>No Assignment or Transfer;
Beneficiaries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) Awards under
the Plan shall not be assignable or transferable by the Participant, except by will or by the laws of descent and distribution, and shall
not be subject in any manner to assignment, alienation, pledge, encumbrance or charge. Notwithstanding the foregoing, the Committee may
provide in an Award Agreement that the Participant shall have the right to designate a beneficiary or beneficiaries who shall be entitled
to any rights, payments or other benefits specified under an Award following the Participant&rsquo;s death. During the lifetime of a Participant,
an Award shall be exercised only by such Participant or such Participant&rsquo;s guardian or legal representative. In the event of a Participant&rsquo;s
death, an Award may, to the extent permitted by the Award Agreement, be exercised by the Participant&rsquo;s beneficiary as designated
by the Participant in the manner prescribed by the Committee or, in the absence of an authorized beneficiary designation, by the legatee
of such Award under the Participant&rsquo;s will or by the Participant&rsquo;s estate in accordance with the Participant&rsquo;s will
or the laws of descent and distribution, in each case in the same manner and to the same extent that such Award was exercisable by the
Participant on the date of the Participant&rsquo;s death.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) <U>Limited Transferability
Rights</U><I>.</I> Notwithstanding anything else in this Section 15.3 to the contrary, the Committee may in its discretion provide in
an Award Agreement that an Award in the form of a Nonqualified Stock Option, share-settled Stock Appreciation Right, Restricted Stock,
Performance Share or share-settled Other Stock-Based Award may be transferred, on such terms and conditions as the Committee deems appropriate,
either (i) by instrument to the Participant&rsquo;s &ldquo;Immediate Family&rdquo; (as defined below), (ii) by instrument to an inter
vivos or testamentary trust (or other entity) in which the Award is to be passed to the Participant&rsquo;s designated beneficiaries,
or (iii) by gift to charitable institutions. Any transferee of the Participant&rsquo;s rights shall succeed and be subject to all of the
terms of the applicable Award Agreement and the Plan. &ldquo;<B>Immediate Family</B>&rdquo; means any child, stepchild, grandchild, parent,
stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law,
or sister-in-law, and shall include adoptive relationships.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.4 <U>Rights as Stockholder.</U>
A Participant shall have no rights as a holder of shares of Common Stock with respect to any unissued shares of Common Stock covered by
an Award until the date the Participant becomes the holder of record of such securities. Except as provided in Section 4.2 hereof, no
adjustment or other provision shall be made for dividends or other stockholder rights, except to the extent that the Award Agreement provides
for dividend payments or dividend equivalent rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.5 <U>Employment or Continuous
Service.</U> Nothing in the Plan, in the grant of any Award or in any Award Agreement shall confer upon any Eligible Person or Participant
any right to continue in Continuous Service, or interfere in any way with the right of the Company or any of its Subsidiaries to terminate
the employment or other service relationship of an Eligible Person or Participant for any reason at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.6 <U>Fractional Shares.</U>
In the case of any fractional share or unit resulting from the grant, vesting, payment or crediting of dividends or dividend equivalents
under an Award, the Committee shall have the discretionary authority to (i) disregard such fractional share or unit, (ii) round such fractional
share or unit to the nearest lower or higher whole share or unit, or (iii) convert such fractional share or unit into a right to receive
a cash payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.7 <U>Other Compensation
and Benefit Plans.</U> The amount of any compensation deemed to be received by a Participant pursuant to an Award shall not constitute
includable compensation for purposes of determining the amount of benefits to which a Participant is entitled under any other compensation
or benefit plan or program of the Company or any Subsidiary, including, without limitation, under any bonus, pension, profit-sharing,
life insurance, salary continuation or severance benefits plan, except to the extent specifically provided by the terms of any such plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.8 <U>Plan Binding on Transferees.</U>
The Plan shall be binding upon the Company, its transferees and assigns, and the Participant, the Participant&rsquo;s executor, administrator
and permitted transferees and beneficiaries. In addition, all obligations of the Company under this Plan with respect to Awards granted
hereunder shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect
purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.9 <U>Foreign Jurisdictions.</U>
The Committee may adopt, amend and terminate such arrangements and grant such Awards, not inconsistent with the intent of the Plan, as
it may deem necessary or desirable to comply with any tax, securities, regulatory or other laws of other jurisdictions with respect to
Awards that may be subject to such laws. The terms and conditions of such Awards may vary from the terms and conditions that would otherwise
be required by the Plan solely to the extent the Committee deems necessary for such purpose. Moreover, the Board may approve such supplements
to or amendments, restatements or alternative versions of the Plan, not inconsistent with the intent of the Plan, as it may consider necessary
or appropriate for such purposes, without thereby affecting the terms of the Plan as in effect for any other purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.10 <U>No Obligation to
Notify or Minimize Taxes</U>. The Company will have no duty or obligation to any Participant to advise such holder as to the time or manner
of exercising an Award. Furthermore, the Company will have no duty or obligation to warn or otherwise advise such holder of a pending
termination or expiration of an Award or a possible period in which the Award may not be exercised. The Company has no duty or obligation
to minimize the tax consequences of an Award to the holder of such Award.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.11 <U>Corporate Action
Constituting Grant of Awards</U>. Corporate action constituting a grant by the Company of an Award to any Participant will be deemed completed
as of the date of such corporate action, unless otherwise determined by the Committee or the Board, regardless of when the instrument,
certificate, or letter evidencing the Award is communicated to, or actually received or accepted by, the Participant. In the event that
the corporate records (e.g., Board or Committee consents, resolutions or minutes) documenting the corporate action constituting the grant
contain terms (e.g., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement as
a result of a clerical error in the papering of the Award Agreement, the corporate records will control and the Participant will have
no legally binding right to the incorrect term in the Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.12 <U>Change in Time Commitment</U>.
In the event a Participant&rsquo;s regular level of time commitment in the performance of the Participant&rsquo;s services for the Company
and any Affiliates is reduced (for example, and without limitation, if the Participant is an employee of the Company and the employee
has a change in status from a full-time employee to a part-time employee) after the date of grant of any Award to the Participant, the
Committee has the right in its sole discretion to (i) make a corresponding reduction in the number of shares subject to any portion of
such Award that is scheduled to vest or become payable after the date of such change in time commitment and (ii) in lieu of or in combination
with such a reduction, extend the vesting or payment schedule applicable to such Award. In the event of any such reduction, the Participant
will have no right with respect to any portion of the Award that is so reduced or extended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.13 <U>Substitute Awards
in Corporate Transactions.</U> Nothing contained in the Plan shall be construed to limit the right of the Committee to grant Awards under
the Plan in connection with the acquisition, whether by purchase, merger, consolidation or other corporate transaction, of the business
or assets of any corporation or other entity. Without limiting the foregoing, the Committee may grant Awards under the Plan to an employee
or director of another corporation who becomes an Eligible Person by reason of any such corporate transaction in substitution for awards
previously granted by such corporation or entity to such person. The terms and conditions of the substitute Awards may vary from the terms
and conditions that would otherwise be required by the Plan solely to the extent the Committee deems necessary for such purpose. Any shares
of Common Stock subject to these substitute Awards shall not be counted against any of the maximum share limitations set forth in the
Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Legal Compliance</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.1 <U>Securities Laws</U>.
No shares of Common Stock will be issued or transferred pursuant to an Award unless and until all then applicable requirements imposed
by Federal and state securities and other laws, rules and regulations and by any regulatory agencies having jurisdiction, and by any exchanges
upon which the shares of Common Stock may be listed, have been fully met. As a condition precedent to the issuance of shares pursuant
to the grant or exercise of an Award, the Company may require the Participant to take any reasonable action to meet such requirements.
The Committee may impose such conditions on any shares of Common Stock issuable under the Plan as it may deem advisable, including, without
limitation, restrictions under the Securities Act, as amended, under the requirements of any exchange upon which such shares of the same
class are then listed, and under any blue sky or other securities laws applicable to such shares. The Committee may also require the Participant
to represent and warrant at the time of issuance or transfer that the shares of Common Stock are being acquired only for investment purposes
and without any current intention to sell or distribute such shares. All Common Stock issued pursuant to the terms of this Plan shall
constitute &ldquo;restricted securities,&rdquo; as that term is defined in Rule 144 promulgated pursuant to the Securities Act, and may
not be transferred except in compliance herewith and with the registration requirements of the Securities Act or an exemption therefrom.
Certificates representing Common Stock acquired pursuant to an Award may bear such legend as the Company may consider appropriate under
the circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.2 <U>Incentive Arrangement</U>.
The Plan is designed to provide an on-going, pecuniary incentive for Participants to produce their best efforts to increase the value
of the Company. The Plan is not intended to provide retirement income or to defer the receipt of payments hereunder to the termination
of a Participant&rsquo;s employment or beyond. The Plan is thus intended not to be a pension or welfare benefit plan that is subject to
Employee Retirement Income Security Act of 1974 (&ldquo;<B>ERISA</B>&rdquo;), and shall be construed accordingly. All interpretations
and determinations hereunder shall be made on a basis consistent with the Plan&rsquo;s status as not an employee benefit plan subject
to ERISA.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.3 <U>Unfunded Plan</U>.
The adoption of the Plan and any reservation of shares of Common Stock or cash amounts by the Company to discharge its obligations hereunder
shall not be deemed to create a trust or other funded arrangement. Except upon the issuance of Common Stock pursuant to an Award, any
rights of a Participant under the Plan shall be those of a general unsecured creditor of the Company, and neither a Participant nor the
Participant&rsquo;s permitted transferees or estate shall have any other interest in any assets of the Company by virtue of the Plan.
Notwithstanding the foregoing, the Company shall have the right to implement or set aside funds in a grantor trust, subject to the claims
of the Company&rsquo;s creditors or otherwise, to discharge its obligations under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.4 <U>Section 409A Compliance</U>.
To the extent applicable, it is intended that the Plan and all Awards hereunder comply with the requirements of Section 409A of the Code
or an exemption thereto, and the Plan and all Award Agreements shall be interpreted and applied by the Committee in a manner consistent
with this intent in order to avoid the imposition of any additional tax under Section 409A of the Code. Notwithstanding anything in the
Plan or an Award Agreement to the contrary, in the event that any provision of the Plan or an Award Agreement is determined by the Committee,
in its sole discretion, to not comply with the requirements of Section 409A of the Code or an exemption thereto, the Committee shall,
in its sole discretion, have the authority to take such actions and to make such interpretations or changes to the Plan or an Award Agreement
as the Committee deems necessary, regardless of whether such actions, interpretations, or changes shall adversely affect a Participant,
subject to the limitations, if any, of Applicable Law. If an Award is subject to Section 409A of the Code, any payment made to a Participant
who is a &ldquo;specified employee&rdquo; of the Company or any Subsidiary shall not be made before the date that is six (6) months after
the Participant&rsquo;s &ldquo;separation from service&rdquo; to the extent required to avoid the adverse consequences of Section 409A
of the Code. For purposes of this Section 16.4, the terms &ldquo;separation from service&rdquo; and &ldquo;specified employee&rdquo; shall
have the meanings set forth in Section 409A of the Code. In no event whatsoever shall the Company be liable for any additional tax, interest
or penalties that may be imposed on any Participant by Section 409A of the Code or any damages for failing to comply with Section 409A
of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.5 <U>Tax Withholding</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) The Company
shall have the power and the right to deduct or withhold, or require a participant to remit to the Company, the minimum statutory amount
to satisfy federal, state, and local taxes, domestic or foreign, required by law or regulation to be withheld with respect to any taxable
event arising as a result of this Plan, but in no event shall such deduction or withholding or remittance exceed the minimum statutory
withholding requirements unless permitted by the Company and such additional withholding amount will not cause adverse accounting consequences
and is permitted under Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) Subject to such
terms and conditions as shall be specified in an Award Agreement, a Participant may, in order to fulfill the withholding obligation, (i)
tender previously-acquired shares of Common Stock or have shares of stock withheld from the exercise, provided that the shares have an
aggregate Fair Market Value sufficient to satisfy in whole or in part the applicable withholding taxes; and/or (ii) utilize the broker-assisted
exercise procedure described in Section 6.5 to satisfy the withholding requirements related to the exercise of a Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) Notwithstanding
the foregoing, a Participant may not use shares of Common Stock to satisfy the withholding requirements to the extent that (i) there is
a substantial likelihood that the use of such form of payment or the timing of such form of payment would subject the Participant to a
substantial risk of liability under Section 16 of the Exchange Act; (ii) such withholding would constitute a violation of the provisions
of any law or regulation, or (iii) such withholding would cause adverse accounting consequences for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.6 <U>No Guarantee of Tax
Consequences</U>. Neither the Company, the Board, the Committee nor any other Person make any commitment or guarantee that any federal,
state, local or foreign tax treatment will apply or be available to any Participant or any other Person hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.7 <U>Severability</U>.
If any provision of the Plan or any Award Agreement shall be determined to be illegal or unenforceable by any court of law in any jurisdiction,
the remaining provisions hereof and thereof shall be severable and enforceable in accordance with their terms, and all provisions shall
remain enforceable in any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.8 <U>Stock Certificates;
Book Entry Form</U>. <FONT STYLE="background-color: white">Notwithstanding any provision of the Plan to the contrary, unless otherwise
determined by the Committee or required by any Applicable Law, rule or regulation, any obligation set forth in the Plan pertaining to
the delivery or issuance of stock certificates evidencing shares of Common Stock may be satisfied by having issuance and/or ownership
of such shares recorded on the books and records of the </FONT>Company <FONT STYLE="background-color: white">(or, as applicable, its transfer
agent or stock plan administrator).</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.9 <U>Governing Law.</U>
The Plan and all rights hereunder shall be subject to and interpreted in accordance with the laws of the State of Delaware, without reference
to the principles of conflicts of laws, and to applicable Federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Effective Date, Amendment and Termination</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">17.1 <U>Effective Date</U>.
The effective date of the Plan shall be the date on which the Plan is approved by the requisite percentage of the holders of the Common
Stock of the Company; provided, however, that Awards granted under the Plan subsequent to the approval of the Plan by the Board shall
be valid if such stockholder approval occurs within one (1) year of the date on which such Board approval occurs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">17.2 <U>Amendment; Termination</U>.
The Board may suspend or terminate the Plan (or any portion thereof) at any time and may amend the Plan at any time and from time to time
in such respects as the Board may deem advisable or in the best interests of the Company or any Subsidiary; provided, however, that (a)
no such amendment, suspension or termination shall materially and adversely affect the rights of any Participant under any outstanding
Awards, without the consent of such Participant, (b) to the extent necessary and desirable to comply with any Applicable Law, regulation,
or stock exchange rule, the Company shall obtain stockholder approval of any Plan amendment in such a manner and to such a degree as required,
and (c) stockholder approval is required for any amendment to the Plan that (i) increases the number of shares of Common Stock available
for issuance under the Plan, or (ii) changes the persons or class of persons eligible to receive Awards. Notwithstanding any other provision
of the Plan or any Award Agreement to the contrary, the Committee may, in its sole and absolute discretion and without the consent of
any Participant, amend the Plan or any Award Agreement, (i) to take effect retroactively or otherwise, as it deems necessary or advisable
for the purpose of conforming the Plan or such Award Agreement to any present or future law, regulation or rule applicable to the Plan,
including, but not limited to, Section 409A of the Code, or (ii) in a manner that causes an Incentive Stock Option to be treated as a
Nonqualified Stock Option. The Plan will continue in effect until terminated in accordance with this Section 17.2; <I>provided, however,</I>
that no Award will be granted hereunder on or after October 6, 2033 (the &ldquo;<B>Expiration Date</B>&rdquo;); <I>but provided further,
</I>that Awards granted prior to such Expiration Date may extend beyond that date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">BOARD APPROVAL: <B>October 6, 2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">STOCKHOLDER APPROVAL: <B>December 19, 2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">19</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>ktta-20231219_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://pasithea.com/role/Cover" xlink:href="ktta-20231219.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://pasithea.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ktta-20231219.xsd#KTTA_CommonStockParValue0.0001PerShareMember" xlink:label="loc_KTTACommonStockParValue0.0001PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_KTTACommonStockParValue0.0001PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ktta-20231219.xsd#KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" xlink:label="loc_KTTAWarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_KTTAWarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ktta-20231219_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ktta-20231219.xsd#KTTA_CommonStockParValue0.0001PerShareMember" xlink:label="KTTA_CommonStockParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KTTA_CommonStockParValue0.0001PerShareMember" xlink:to="KTTA_CommonStockParValue0.0001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KTTA_CommonStockParValue0.0001PerShareMember_lbl" xml:lang="en-US">Common Stock, par value $0.0001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="ktta-20231219.xsd#KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" xlink:label="KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" xlink:to="KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember_lbl" xml:lang="en-US">Warrants to purchase shares of Common Stock, par value $0.0001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ktta-20231219_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://pasithea.com/role/Cover" xlink:href="ktta-20231219.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://pasithea.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ktta-20231219.xsd#KTTA_CommonStockParValue0.0001PerShareMember" xlink:label="loc_KTTACommonStockParValue0.0001PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_KTTACommonStockParValue0.0001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ktta-20231219.xsd#KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" xlink:label="loc_KTTAWarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_KTTAWarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>ktta-20231219.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 8qI5s7xRiXgen8uOYHxcWaGHOcP9zp5yWZlBvGd4HSnKfyEuC/13cCPmdpamsWQJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:KTTA="http://pasithea.com/20231219" elementFormDefault="qualified" targetNamespace="http://pasithea.com/20231219">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://pasithea.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="ktta-20231219_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ktta-20231219_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ktta-20231219_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="KTTA_CommonStockParValue0.0001PerShareMember" name="CommonStockParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" name="WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140243288487296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 19, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 19,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Pasithea Therapeutics Corp.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001841330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">85-1591963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4400 Route 9 South<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 3100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Miami Beach<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">977-3380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=KTTA_CommonStockParValue0.0001PerShareMember', window );">Common Stock, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KTTA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember', window );">Warrants to purchase shares of Common Stock, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants to purchase shares of Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KTTAW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=KTTA_CommonStockParValue0.0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=KTTA_CommonStockParValue0.0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>ea190360-8k_pasithea_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:KTTA="http://pasithea.com/20231219"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ktta-20231219.xsd" xlink:type="simple"/>
    <context id="AsOf2023-12-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001841330</identifier>
        </entity>
        <period>
            <startDate>2023-12-19</startDate>
            <endDate>2023-12-19</endDate>
        </period>
    </context>
    <context id="From2023-12-192023-12-19_custom_CommonStockParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001841330</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">KTTA:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-19</startDate>
            <endDate>2023-12-19</endDate>
        </period>
    </context>
    <context id="From2023-12-192023-12-19_custom_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001841330</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">KTTA:WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-19</startDate>
            <endDate>2023-12-19</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2023-12-19">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2023-12-19">0001841330</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2023-12-19">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2023-12-19">2023-12-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2023-12-19">Pasithea Therapeutics Corp.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2023-12-19">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2023-12-19">001-40804</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2023-12-19">85-1591963</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2023-12-19">4400 Route 9 South</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2023-12-19">Suite 3100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2023-12-19">Miami Beach</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2023-12-19">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2023-12-19">33139</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2023-12-19">786</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2023-12-19">977-3380</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2023-12-19">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2023-12-19">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2023-12-19">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2023-12-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-12-192023-12-19_custom_CommonStockParValue0.0001PerShareMember">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-12-192023-12-19_custom_CommonStockParValue0.0001PerShareMember">KTTA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-12-192023-12-19_custom_CommonStockParValue0.0001PerShareMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2023-12-192023-12-19_custom_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember">Warrants to purchase shares of Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-12-192023-12-19_custom_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember">KTTAW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-12-192023-12-19_custom_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2023-12-19">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2023-12-19">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
MHXJ35Y3ME9W2!   OQ0  !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6RU
MF&MSZC80AO^*QNUTVIDD^$*XI, ,N;697 X-G&:FWX2]@.;8EH\DA^3?=V7
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M',$8  <,2=/^/7CW/DK&]U1R^8^P^0E02P,$%     @ HXJ35Y>*NQS
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M7F=Z_S!YU!Y:YU;*O8=7LN48<?R>Y0]02P,$%     @ HXJ35R0>FZ*M
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "CBI-7(=Y]".T    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "C
MBI-7F5R<(Q &  "<)P  $P              @ '+ 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( *.*DU>4[96=T@0  +\4   8
M  " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "C
MBI-7X/0ZB:H"   P#   #0              @ $4#0  >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( *.*DU>7BKL<P    !,"   +              "  >D/
M  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( *.*DU>JQ"(6,P$  "("   /
M          "  =(0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "CBI-7
M)!Z;HJT   #X 0  &@              @ $R$@  >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " "CBI-799!YDAD!  #/ P  $P
M        @ $7$P  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"
(  !A%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea190360-8k_pasithea.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pasithea.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea190360-8k_pasithea.htm">ea190360-8k_pasithea.htm</File>
    <File>ktta-20231219.xsd</File>
    <File>ktta-20231219_def.xml</File>
    <File>ktta-20231219_lab.xml</File>
    <File>ktta-20231219_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea190360-8k_pasithea.htm": {
   "nsprefix": "KTTA",
   "nsuri": "http://pasithea.com/20231219",
   "dts": {
    "inline": {
     "local": [
      "ea190360-8k_pasithea.htm"
     ]
    },
    "schema": {
     "local": [
      "ktta-20231219.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "ktta-20231219_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ktta-20231219_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ktta-20231219_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 27
   },
   "report": {
    "R1": {
     "role": "http://pasithea.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-19",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea190360-8k_pasithea.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-19",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea190360-8k_pasithea.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "KTTA_WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://pasithea.com/20231219",
     "localname": "WarrantsToPurchaseSharesOfCommonStockParValue0.0001PerShareMember",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants to purchase shares of Common Stock, par value $0.0001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "KTTA_CommonStockParValue0.0001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://pasithea.com/20231219",
     "localname": "CommonStockParValue0.0001PerShareMember",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.0001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://pasithea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001213900-23-097013-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-23-097013-xbrl.zip
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M@UX,Q@[=A?RB+UK5W&233NTFK5:+:EJ@$?%+<3G<*1+OMOSG&E8>S;$._K&
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M!@P5I&Q989Q#=R&B_<.Y@V8!%@X(Y[0M>:BS$LT0S%#@!L*;,9$R >VYJ/Y
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M_N/1\:-'CTXPKL:>]#W3'["R)^'*XK(E%E5K7_%VB$I?T55]!7?Z)1;?:!D
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M'Q]$7&0L/R6CLX'-TG+)5.;R_BVN39 D\B(<1,75S;54VR?L/7Z/2 )<NH
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M_#$:XK\VV2\*%GZ1O8'O+&MRRS2L )+^:_*ZQ/V/:>US]Q<)M.(V(02 U?"
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M;D^3HJSMK$JSM";UQM-VNUT\O./!!:K(BAUU4&++1O02\XPW3B]=3R&-2HA
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M* PM.7,IK'*^ QKP)B?QE$^BK?2P?.!C1>4):UMM55NO>C7P,&$IHCSZ<L2
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M23!EY"O&*_V )*?2G,EW7!_-LE&1!4LCT8B,Y1ZVWYBC&VU''0M=!-4I]/#
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M 5'[=%%.T+,'H0&OZ5[.MU-^SG(!'2IL^IZ",HB,YJ](.4*2Q-YQP-BDFDL
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MB 7ILF-<0_Z_C6L$@_P<*T3O^/K'WU[]SP_X'__U_F^__/#_ %!+ P04
M" "CBI-7\WQRG<L#   !#P  $0   &MT=&$M,C R,S$R,3DN>'-DO5=;=]HX
M$'[?<_8_:/UNC&&S+2ZTITLV"6W2L($V[;[T"%D&G=B2*\F!]-=W)%\"& BP
M37F29[YO+M)H-'3?+)(8W5.IF. ]QV\T'40Y$2'CTY[S<>2^'?4' P>]>?W[
M;PA^W3]<%YTQ&H<!.A7$'?!(O$(?<$(#=$XYE5@+^0I]PG%F).*,Q52BODC2
MF&H*BMQ3@$X:K29!KKN'W4^4AT)^O!E4=F=:IRKPO/E\WN#B'L^%O%,-(I+]
M#(XTUIFJK#47S>*W'_V**5*17WX;G*@7BQOV>4KYR^SZR\6"W.+SBVLR['Q/
M3QYN_XO_OC\/_[P8\??1PS]9W_/;I#],PA0GZO;?=[G+KB(SFF $A\%5SS'Y
M%>G-VPTAIUZKV?2]SU>7(XMS<F"PB!F_VP3W.YV.9[4EM(9<3&1<FFY[1CW!
MBE:60<MVX!E7&G.R@@]U15@&GWBY<@7*-D+_RJ&LA(9T#:<H:4S%O0<*P+?:
M)3!3[A3CM )'6$VLT4*Q E92UX$@7 >Y^B&E:B,T5ZT00BW7""N[!FK/J VG
MY3;;;MLOF>_'X[<5*<6*Z1G%IIJM?;_E=^!.QC2A7)\)F9S2"&<QI/ MPS&+
M& T=I+&<4FW*4Z68T">LE36..1=P%> ^%A(C2U,&M5X)0&1J(Y BIF.('YD%
MW,7-+HS2ZPOH)PYB8<_)ETO&2G,AC1AGUG5Q]WSDFIN6F31A:9E=;QU<MY0I
M&E[SUW:=2JJ ;E.Z!$'!+R"[N03')(N/HC[&MXM9R,N-K.UP>05O:(3LU0U,
MO?0<Q4SS= K93-*HY]QIC=WR/+]"V@THI1)B/.RXNO:,UG>J<%R:P)+4K-1:
M"Q@1*96:P4U8ZA]YZ$P;^G#)#3)^E(.\GYAYC">'9@X4&C]CRI?&_G/D"E5V
M:*ZKA?E,"9]63NI9=[W5?@+?ZSVG"XD+J1&O-:]=KT[^7EX*8DWMH)@OM^2Y
M1N3Z+6B^C84*'R,])(C';3@LB))W1!!;WKY-_M4VN%G88MK7Z98W=*?3C1R/
MQEJ5DJ-#6'YQ_T<,ULQ!03S]C&\+YRFF_59'%0$1&=?RX9!"6*:4'\>=QN.L
MM-]!E/C\$,SX=*S;(ZJ@[GQK"11#EIU<S%#V%?ZW)(*/M"!W0RSMQ-]LF%EE
M2.5HAB6]HLG$S#HF:C/M[ MG,3Q#IGEJF9E^:J;M /HL$^'8/@=A)FU6,-KE
MW^5T&80BP8P/-$T,$G8AFRCHQ)E!GTN1P1"<FV, V97<+982<ZW&8IA),H/.
M9&-4U]&!:?\,0[]V0[I>7CNP_ %02P,$%     @ HXJ35Z8?OZGZ"   R6@
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MJ&L"(L%J#*!AKU5+CKP0<29Z)HZ32[H@NX_D":Q70^>6"<!F'0I#%! 5=F<
M%KD8*342<B]@W/)XC?G3-(XZAHJFT"T:D-$Z&Z8J(#@ :P =N1I-+\]\CB0S
MO+M<"%#C9:R7"W90 NK=PM)AN\X,( X(G7:' $$B"-6C?()T22/&-ZSRN,,9
MVXH.\.F,+> 92D>46ZAZ5:&.5FM(0(#U\0E@5@M]HY])04PN\U8%(%F"%^).
M%PMQHM+\GZN8DC%8?ZO6+5TM=NM,680!D02[ _C)E6^*#TC&H!L:"C239U1U
MXA^:25]H)D%#,WD)-+-'%@@T1\^HZI%_:([Z0G,4-#1'+X)&-+S7ON9,?+SA
M,_9H>S@;5'I!IFG5"LQ>%AXN#6]=L,@ .9^1(3XQ41.K&W[+V4-,(WC*#,F]
M  .8ME)C:,-#QVZPBY]R0ES$>>UK]*2\\TM2R/ST,G63]BY&:\*#I&ZLLW/1
M:I](W+(TP\E_XTWKA;A=[ 4/JV$K)#5E>*C8['4!HV.0"/)Q89WC*G_0L"XE
M,_8[^[799JO\B;FZ,P@(;(Z:>3;TW1,M<MW,DE%.,- CU'<[:V2+J;*-*_O"
M:.*FH48+J^^UT/CX(LOD?\GM':/P P)-B:N6ALP5K6WN#Z+% 5-FJRL94CI/
M=^-E K+4WGU7]CD;V4T[Y4!>[ BB=4TWC6&ZV.^X-;_Q.!-'EDEHMC3_E<?V
MW""@<]7*K3:+%K>*@FC]-F>-=$%:B^IBQUA,61)'<1;3U2=Q\<EC;*N53>0*
M"-A@04-3$00*H*U&)I=2B JE8PAN.9$0$M$0:A&@S#O);Y9+ZVC?)G8%1;?A
M @Y8&00DG?9,6$3 ,*I$(!V"5(Q?;"[3=$OXL^"QA'A""#0/@-30AX@39+(3
M*AWHDZTIB;9B?'P:3^:S.&LDH;-+G(U)@+ER1#+V!\$&8,ID0>V3Z0K'DY_F
M?T=%E./FOV8SCN6[!:9/ZSE+@.Q35I4K"%HL%AQ8)$&@ /LR:;AF*)<BK?61
MG:IFUE(=8[\K *RVBJ:O[0RBT6V.&E_^6EM[ZO+/=]&=,$6 !0EVF>NNWV;2
M[/ZKFB 0:#'6N"C)I:C0^EB0L!^R5MV3@)6W2<"J8Q*P"G$2L.H["5AYFP04
MA]4I0D2_=#-/XA4&DA.VJEU#T6+9Y,,B#0H5V!_89Y0A:!_C.J.E2G$FW][$
MU^KX%^*#I9: SEE.RS:;95)+FR@(1MJ<-=):ZJ1S%3&2:M=<;!=Q1A;:S$5,
M,8UBG)3I$6UWQ+M#G-'2TWP)3H<^#(;ZF6S@I,.*7(9EX#[5I>M;Z?H!C&\D
M23Y2]DBG!*>,DH6^EV+[I:A=[_:)F0[;]8=F '$0./5Q"#PZ(X.&]S(*%6'Y
MG3 O)'UER99FF*NUY-S6,P$ZM^0 -NO$&** 2+$[ P@IQ4BK_2S0UMDCRDF6
M?BTE6$%([GBY=JMI8]6V51L0,ZT&H37<><Z/_=Q81WE:8ID1CJ,L?B ?<(9S
M;V!](;GK195MILW5E#9M0 BU&@373Y8Q,E4,+ICREC*&GXFIUHJU/"5NJ-PG
MCFE8;.:.*24!X6'SU9)!AJ-"ZX6%Z1HGR?MM&E.2P@.1H7++@M5BG86:)" 6
M;+X %I04%5HO+)RO"5^)X>TWSAZSNSP_*U@W0.V6C5;+=4:LTH!8:?,',%.$
M(!U3I-3U \]NGU!<9UF$:VJ1.L8&-&LPT]"%! QDKD%+0B)YO^6:96C&T)>4
MH.R.H//\+<753/"Z'%]O&HDBN2!"S\KI G,;0FUBYV\= 0TWWCW24 8!4J<]
M^#TD900J0AQ3<R,8YM7K.&5"ODL/7.W0'>**H+[F"XZZ]$'0U-.DR90*JU]<
MJT#U7D2?V8RJR>WA*5Y-Y'AF;#%H3(PKBB 8 6U!T^+JNP+\Y,[;SI,XND@8
MAN^RU#2.,^8U[1G)\O:"@ AHNH)2Y"DA4DHO[?\>TWN^W631TRUG$2'R*:NT
M[*VZ[K_UC';+S+.J5*>I5VA G#W'+T#@O@A4*>--9<3R>3.O\M[S_%7HVRR5
M(Z@P!M\%;PUR_/-"CPH8/S*T1 2$7@^;T \.M=?-ZV!4B?9T?9;NLP"2Q?NG
MSV1)N%QW,".[[+TXT'W+%4:/6-=7;[VK8U[,=08& >%SW4*7>BFJ%H#F\AFQ
MO CTNRP$J5)L[R^O;KH2G\3F8I/X:XY3(K;\'U!+ P04    " "CBI-7V1ZV
MST$(  !C8P  %0   &MT=&$M,C R,S$R,3E?<')E+GAM;-6=;7?:-A3'W^^<
M?0>/O28\9-V6M%E/2I,>3A^2!=IN>],C; $Z$1)'DA/X]I,,)H M^;*V7*\O
M4F*NI/O_75G6M27GQ<O%C$</5&DFQ46C<])N1%3$,F%B<M'X.&A>#GK]?B/2
MAHB$<"GH14/(QLL_?OPALO]>_-1L1M>,\N0\>BWC9E^,Y?/H YG1\^@-%501
M(]7SZ!/AJ3LBKQFG*NK)V9Q30^T7JX;/HV<GW78<-9N >C]1D4CU\:Z_J7=J
MS%R?MUJ/CX\G0CZ01ZGN]4DL9[ *!X:85&]J:R_:ZW^KXB\X$_?G[L>(:!I9
M7D*?+S2[:+AVU\T^GIY(-6EUV^U.ZZ_W[P;QE,Y(DPG'+::-O)2KI:Q<Y^SL
MK)5]FYL6+!<CQ?,V3ENY.YN:[;<L8+_EB6;G.G/OG8R)R<)>V4SDM7"_-7.S
MICO4['2;IYV3A4X:.?R,H)*<WM%QY/ZWT=NT.B>:F2DE+F M]V6K)VV'M)YF
MQ::*CB\:]\806WOWM-/MG+FZ?]XQ,LNY[9B:N7[5B%H[[<X5U5283.H[>V"G
M"%T8VYUHDE?DVH=Z9IAQQNO.THF:KF>E,]N6_;BR7#N2N\)EO-,Z=Q&0>U+S
MWIQQUC0^F<B'5D)9R\EW'S(.&0/[RY>LH<N1-HK$)J^)DQ'E6?U?K,V>2>NK
MO1H3/<JZ0*J;$T+F*]<H-SH_\N3C^L 7=Y91!V=(1BY(!4?7AOMV^]YNA_-2
M[7I.5)Q7;#_NQ++8<]<6-LK*UM>,IXQONL%8R9D/W[I!&?1:JH0J.YZVV^B\
M;9^G??M1 YAOV2)S]W -P]]R?QV ;@T"T.-$ZYOQP,CX_G+!('$H%OD_AJ.H
M8G-:8 5EVZ77<D:8\$>CS+9F8?!UK;V(E"E9A^*_1J)X07X['%[:J]%L)D76
MT"U1V8RJ?>*NCK=4#:96VWLZ&SU=0K>@N^+@TE5AV)S]WRD _FZ4DS](3J'7
M?,N0?"9*$6'T4-ZF*I[::5K6MG7_ZX+U#>H%AO$4-XS?#.#7!OC F6$^&QW:
M&LLGAKL6P&A\KV#X)RQY, H>HV"]M.TGSH=K3B;E7/=,@& [J&1+96&A?4UU
MK-C< :H@O&.)?5DX#'2)2*01XHY.F$MOG"L;#>$APU,$>T0_:! )RD8*Q:40
M*>%W="Y5101V+8'@?ZD%^#*12+S_3(DR5/$E!'G!&$C]62VH>Z1BS4KLG$HS
M!PI"OF@-1/]K+=#[Q"*Q'TPIY^XN/!&@?E]F#^3_6RWX^P77( )7#VXR8-7
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M:YOVC@I;7X,7[>$.O?MZCLSSLV+&>N#6?*=B?3_(\P#/8PKEC)M8!G4>F?E
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M<&%S:71H96$N:'1M4$L! A0#%     @ HXJ35VEUEY3U8@  ZS0" !L
M         ( !91\  &5A,3DP,S8P97@Q,"TQ7W!A<VET:&5A+FAT;5!+ 0(4
M Q0    ( *.*DU?S?'*=RP,   $/   1              "  9."  !K='1A
M+3(P,C,Q,C$Y+GAS9%!+ 0(4 Q0    ( *.*DU>F'[^I^@@  ,EH   5
M          "  8V&  !K='1A+3(P,C,Q,C$Y7V1E9BYX;6Q02P$"% ,4
M" "CBI-71]6X&>T+  "?D   %0              @ &ZCP  :W1T82TR,#(S
M,3(Q.5]L86(N>&UL4$L! A0#%     @ HXJ35]D>ML]!"   8V,  !4
M         ( !VIL  &MT=&$M,C R,S$R,3E?<')E+GAM;%!+!08     !@ &
+ )<!  !.I      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
